Compound, polymerizable composition, cured product, optical film, polarizing plate, and image display device

By combining compounds with polymerizable liquid crystal compounds with specific structures, the inclination angle of liquid crystal molecules is reduced, and the image display problem caused by large inclination angle in the optical anisotropic layer is solved, and the viewing angle stability and image quality of the image display device are improved.

CN113646296BActive Publication Date: 2024-11-29FUJIFILM CORP
View PDF 47 Cites 0 Cited by

Patent Information

Application Number
CN202080025535.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-03-24
Publication Date
2024-11-29
Estimated Expiration
2040-03-24

AI Technical Summary

Technical Problem

The inclination angle of liquid crystal molecules in the existing optical anisotropic layer is relatively large, which affects the performance of image display devices, and especially challenges in eliminating image coloring and expanding viewing angles.

Method used

Using the compound P-Sp-Z-G1-(X1-Cy1)n-(X2-A1)m-X3-A2 with a specific structure, the inclination angle of the liquid crystal molecules is reduced to form an optimized An oriented optical film and polarizer for an image display device.

Benefits of technology

Effectively reduce the inclination angle of liquid crystal molecules, improve the performance of image display devices, enhance the stability of viewing angle and eliminate the effect of image coloring.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003284057400000041
    Figure BDA0003284057400000041
  • Figure BDA0003284057400000091
    Figure BDA0003284057400000091
  • Figure BDA0003284057400000101
    Figure BDA0003284057400000101
Patent Text Reader

Abstract

The present invention aims to provide a compound capable of reducing the tilt angle of liquid crystal molecules, and a polymerizable composition, a cured product, an optical film, a polarizing plate and an image display device using the same. The compound of the present invention is a compound represented by the following formula (I). P-Sp-Z-G 1 ‑(X 1 ‑Cy 1 )n‑(X 2 ‑A 1 )m‑X 3 ‑A 2 ……(I)
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a compound, a polymerizable composition, a cured product, an optical film, a polarizing plate and an image display device. Background Art

[0002] In order to eliminate image coloration or expand the viewing angle, optical films such as optical compensation sheets and phase difference films are used in various image display devices.

[0003] As the optical film, a stretched birefringent film is used. However, in recent years, an optical film having an optically anisotropic layer composed of a liquid crystal compound is proposed instead of the stretched birefringent film.

[0004] As such an optically anisotropic layer, for example, Patent Document 1 describes "an optically anisotropic layer comprising a polymerizable composition of one or more polymerizable rod-like liquid crystal compounds exhibiting a smectic phase fixed in a state exhibiting a smectic phase, wherein a direction in which the refractive index of the optically anisotropic layer becomes maximum has a slope of 10° or less with respect to the optically anisotropic layer surface." ([Claim 1]).

[0005] Previous technical literature

[0006] Patent Literature

[0007] Patent Document 1: Japanese Patent Application Publication No. 2015-200861 Summary of the invention

[0008] Technical issues to be solved by the invention

[0009] As a result of studying the optically anisotropic layer described in Patent Document 1, the present inventors have clarified that there is room for further reducing the angle between the deflection direction of the liquid crystal molecules and the layer plane of the optically anisotropic layer (hereinafter referred to as the "tilt angle") by selecting a compound to be formulated together with the polymerizable liquid crystal compound.

[0010] Therefore, an object of the present invention is to provide a compound capable of reducing the tilt angle of liquid crystal molecules, and a polymerizable composition, a cured product, an optical film, a polarizing plate, and an image display device using the compound.

[0011] Means for solving technical problems

[0012] The present inventors have conducted intensive studies to achieve the above-mentioned objects and have found that the tilt angle of liquid crystal molecules can be reduced by using a compound having a predetermined structure, thereby completing the present invention.

[0013] That is, it was found that the above-mentioned subject can be achieved by the following structure.

[0014] [1] A compound represented by the following formula (I).

[0015] P-Sp-ZG 1 -(X 1 -Cy 1 )n-(X 2 -A 1 )mX 3 -A 2 ……(I)

[0016] Here, in the above formula (I),

[0017] Sp represents a single bond, a straight-chain or branched alkylene group having 1 to 12 carbon atoms, or a divalent linking group in which one or more -CH2- constituting a straight-chain or branched alkylene group having 1 to 12 carbon atoms is substituted by -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent.

[0018] Z represents a single bond, -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent.

[0019] X 1 , X 2 and X 3 Each independently represents a single bond, -COO-, -OCO-, -CO-NH- or -NH-CO-.

[0020] G 1 It represents an aromatic ring which may have a substituent or a 1,4-cyclohexylene group which may have a substituent.

[0021] Cy 1 It represents a 1,4-cyclohexylene group which may have a substituent.

[0022] A 1 It represents an aromatic ring which may have a substituent.

[0023] A 2 represents an aromatic ring or cyclohexane ring which may have a substituent R, wherein the substituent R represents a linear or branched alkoxy group having 1 to 11 carbon atoms, a linear or branched alkyl group having 1 to 12 carbon atoms, or -Z-Sp-P, wherein Z and Sp are the same as above. 2 When it is a 6-membered aromatic ring, relative to X 3 The bonding position of does not have a substituent R at the para position. Furthermore, when the substituent R is -Z-Sp-P, the two Zs, Sps, and Ps in the formula may be the same as or different from each other.

[0024] n represents 0 or 1, m represents an integer of 0 to 2, and n+m represents an integer of 1 to 3. When m is 2, there are 2 X in the formula 2 and A 1 They may be the same as or different from each other.

[0025] P represents a polymerizable group. 2 In the case of an aromatic ring having -Z-Sp-P as a substituent R, one of two Ps present in the formula represents a polymerizable group, and the other represents a hydrogen atom or a polymerizable group.

[0026] Among them, when G 1 When it is an aromatic ring which may have a substituent, n is 0, and m is 1, X 3 It represents -COO-, -OCO-, -CO-NH- or -NH-CO-.

[0027] And, when G 1 is an aromatic ring which may have a substituent, n is 1, m is 0, A 2 When it is an aromatic ring which may have a substituent R, Z represents a single bond, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent. When Z is a single bond, the divalent linking group constituting Sp is 1 The adjacent atom is not an oxygen atom.

[0028] [2] The compound according to [1], wherein

[0029] In the above formula (1), the sum of n and m is 1.

[0030] [3] The compound according to [1] or [2], wherein

[0031] Sp in the above formula (1) is a linear or branched alkylene group having 1 to 3 carbon atoms.

[0032] [4] The compound according to any one of [1] to [3], wherein

[0033] A in the above formula (1) 2 is an aromatic ring which may have a substituent R.

[0034] [5] The compound according to any one of [1] to [4], wherein

[0035] A in the above formula (1) 2 is relative to X 3 The bonding position is a 6-membered aromatic ring having a substituent R at the ortho or meta position.

[0036] [6] The compound according to any one of [1] to [5], wherein

[0037] The substituent R is -Z-Sp-P.

[0038] [7] The compound according to any one of [1] to [3], wherein

[0039] A in the above formula (1) 2 It is an unsubstituted 6-membered aromatic ring.

[0040] [8] The compound according to any one of [1] to [7], wherein

[0041] A in the above formula (1) 2 is a benzene ring which may have a substituent R.

[0042] [9] The compound according to any one of [1] to [8], wherein

[0043] In the above formula (1), m is 0.

[0044]

[10] The compound according to any one of [1] to [9], wherein

[0045] In the above formula (1), n ​​is 1.

[0046]

[11] The compound according to any one of [1] to [8], wherein

[0047] In the above formula (1), n ​​is 0.

[0048]

[12] The compound according to any one of [1] to

[11] , wherein

[0049] P in the above formula (1) is a polymerizable group represented by any one of the following formulae (P-1) to (P-9),

[0050] [Chemical formula 1]

[0051]

[0052]

[13] The compound according to any one of [1] to

[12] , wherein

[0053] In the above formula (1), G 1 It is a 1,4-cyclohexylene group which may have a substituent.

[0054]

[14] The compound according to any one of [1] to

[12] , wherein

[0055] In the above formula (1), G 1 It is an aromatic ring which may have a substituent.

[0056]

[15] A polymerizable composition comprising the compound according to any one of [1] to

[14] .

[0057]

[16] The polymerizable composition according to

[15] , comprising a polymerizable liquid crystal compound different from the above-mentioned compound.

[0058]

[17] The polymerizable composition according to

[16] , wherein

[0059] The above compound and the above polymerizable liquid crystal compound have different polymerizable groups.

[0060]

[18] The polymerizable composition according to any one of

[15] to

[17] , comprising a polymerization initiator.

[0061]

[19] A cured product obtained by curing the polymerizable composition according to any one of

[15] to

[18] .

[0062]

[20] An optical film comprising the cured product described in

[19] .

[0063]

[21] A polarizing plate comprising the optical film described in

[20] and a polarizer.

[0064]

[22] An image display device comprising the optical film described in

[20] or the polarizing plate described in

[21] .

[0065] Effects of the Invention

[0066] According to the present invention, there can be provided a compound capable of reducing the tilt angle of liquid crystal molecules, and a polymerizable composition, a cured product, an optical film, a polarizing plate, and an image display device using the compound. BRIEF DESCRIPTION OF THE DRAWINGS

[0067] Figure 1A This is a schematic cross-sectional view showing an example of the optical film of the present invention.

[0068] Figure 1B This is a schematic cross-sectional view showing an example of the optical film of the present invention.

[0069] Figure 1C This is a schematic cross-sectional view showing an example of the optical film of the present invention. DETAILED DESCRIPTION

[0070] Hereinafter, the present invention will be described in detail.

[0071] Although the description of the constituent elements described below may be based on typical embodiments of the present invention, the present invention is not limited to such embodiments.

[0072] In addition, in this specification, the numerical range expressed using "to" means a range including the numerical values ​​described before and after "to" as the lower limit and the upper limit.

[0073] In addition, in this specification, each component can use a single substance corresponding to each component, or two or more substances can be used simultaneously. Here, when two or more substances are used simultaneously for each component, the content of the component refers to the total content of the substances used simultaneously unless otherwise specified.

[0074] [Compound]

[0075] The compound of the present invention is a compound represented by the following formula (I) (hereinafter, also simply referred to as "compound (I)").

[0076] P-Sp-ZG 1 -(X 1 -Cy 1 )n-(X 2 -A 1 )mX 3 -A 2 ……(I)

[0077] In the present invention, as described above, the tilt angle of the liquid crystal molecules can be reduced by using the compound (I).

[0078] Although the details are not yet clear, the present inventors speculate as follows.

[0079] First, from the viewpoint of fixing the alignment state, it is considered that a polymerizable liquid crystal compound is usually polymerized after being aligned, but the curing shrinkage accompanying the polymerization causes deformation in the liquid crystal molecules, resulting in a tilt angle.

[0080] Therefore, it is believed that in the present invention, compound (I) enters the gaps or interlayers of the polymerizable liquid crystal compound and participates in the polymerization reaction after orientation, thereby suppressing the deformation of the liquid crystal molecules observed only when the liquid crystal compound is polymerized, thereby reducing the tilt angle of the liquid crystal molecules.

[0081] Hereinafter, regarding the compound of the present invention, the structure of the above formula (I) will be described in detail.

[0082] As described above, the compound of the present invention is a compound represented by the following formula (I).

[0083] P-Sp-ZG 1 -(X 1 -Cy 1 )n-(X 2 -A 1 )mX 3 -A 2……(I)

[0084] In the above formula (I), Sp represents a single bond, a straight-chain or branched alkylene group having 1 to 12 carbon atoms, or a divalent connecting group in which one or more -CH2- constituting a straight-chain or branched alkylene group having 1 to 12 carbon atoms is substituted by -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent.

[0085] Furthermore, in the above formula (I), Z represents a single bond, -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent.

[0086] Furthermore, in the above formula (I), X 1 , X 2 and X 3 Each independently represents a single bond, -COO-, -OCO-, -CO-NH- or -NH-CO-.

[0087] Furthermore, in the above formula (I), G 1 It represents an aromatic ring which may have a substituent or a 1,4-cyclohexylene group which may have a substituent.

[0088] Furthermore, in the above formula (I), Cy 1 It represents a 1,4-cyclohexylene group which may have a substituent.

[0089] Furthermore, in the above formula (I), A 1 It represents an aromatic ring which may have a substituent.

[0090] Furthermore, in the above formula (I), A 2 represents an aromatic ring or cyclohexane ring which may have a substituent R, wherein the substituent R represents a linear or branched alkoxy group having 1 to 11 carbon atoms, a linear or branched alkyl group having 1 to 12 carbon atoms, or -Z-Sp-P, wherein Z and Sp are the same as above. 2 When it is a 6-membered aromatic ring, relative to X 3 The bonding position of does not have a substituent R at the para position. Furthermore, when the substituent R is -Z-Sp-P, the two Zs, Sps, and Ps in the formula may be the same as or different from each other.

[0091] In the above formula (I), n represents 0 or 1, m represents an integer of 0 to 2, and n+m represents an integer of 1 to 3. When m is 2, there are 2 X 2 and A 1 can be the same or different from each other,

[0092] Furthermore, in the above formula (I), P represents a polymerizable group. 2 In the case of an aromatic ring having -Z-Sp-P as a substituent R, one of two Ps present in the formula represents a polymerizable group, and the other represents a hydrogen atom or a polymerizable group.

[0093] Wherein, in the above formula (I), when G 1 When it is an aromatic ring which may have a substituent, n is 0, and m is 1, X 3 It represents -COO-, -OCO-, -CO-NH- or -NH-CO-.

[0094] Furthermore, in the above formula (I), when G 1 is an aromatic ring which may have a substituent, n is 1, m is 0, A 2 When it is an aromatic ring which may have a substituent R, Z represents a single bond, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent. When Z is a single bond, the divalent linking group constituting Sp is 1 The adjacent atom is not an oxygen atom.

[0095] In the above formula (I), the linear or branched alkylene group having 1 to 12 carbon atoms represented by one embodiment of Sp preferably includes methylene, ethylene, propylene, butylene, pentylene, hexylene, methylhexylene, and heptylene.

[0096] In addition, as described above, Sp may be a divalent linking group in which one or more -CH2- constituting a linear or branched alkylene group having 1 to 12 carbon atoms is substituted by -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-. As the substituent represented by Q, there may be mentioned the following G 1 The substituents that may be present are the same as the group.

[0097] In the present invention, Sp in the above formula (I) is preferably a linear or branched alkylene group having 1 to 3 carbon atoms because the tilt angle of the liquid crystal molecules can be further reduced.

[0098] In the above formula (I), Z represents a single bond, -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent. In addition, examples of the substituent represented by Q include the following: 1 The substituents that may be present are the same as the group.

[0099] Among these, a single bond, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO- is preferred because of ease of synthesis. 1 In the case of an aromatic ring which may have a substituent, a single bond is preferred.

[0100] In the above formula (I), X 1 , X 2 and X 3 Each independently represents a single bond, -COO-, -OCO-, -CO-NH- or -NH-CO-.

[0101] Among these, about X 1 In the above formula (I), n is 1, and G described below 1 In the case of an aromatic ring which may have a substituent, a single bond is preferred. In the above formula (I), n is 1, and G described below is 1 In the case of an aromatic ring which may have a substituent, -COO- or -OCO- is preferred.

[0102] And, about X 2 In the case where m in the above formula (I) is 1 or 2, with respect to X 2 , preferably -COO- or -OCO-.

[0103] And, about X 3 When m in the above formula (I) is 0, G 1 Regardless of the type of -COO- or -OCO-, when m is 1 or 2, it is preferably a single bond.

[0104] In the above formula (I), G 1 The aromatic ring represented by one embodiment of the present invention includes, for example, aromatic hydrocarbon rings such as a benzene ring, a naphthalene ring, an anthracene ring, and a phenanthroline ring; and aromatic heterocyclic rings such as a furan ring, a thiophene ring, a pyrrole ring, an oxazole ring, an isoxazole ring, an oxadiazole ring, a thiazole ring, an isothiazole ring, a thiadiazole ring, an imidazole ring, a pyrazole ring, a triazole ring, a furazan ring, a tetrazole ring, a pyridine ring, a pyridazine ring, a pyrimidine ring, a pyrazine ring, a triazine ring, a tetrazine ring, and a benzothiazole ring. Among them, a benzene ring (e.g., 1,4-phenyl, etc.) is preferred.

[0105] And, about G 1 Examples of the substituent that the aromatic ring or the 1,4-cyclohexylene group may have include an alkyl group, an alkoxy group, and a halogen atom.

[0106] As the alkyl group, for example, a linear, branched or cyclic alkyl group having 1 to 18 carbon atoms is preferred, an alkyl group having 1 to 8 carbon atoms (for example, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclohexyl, etc.) is more preferred, an alkyl group having 1 to 4 carbon atoms is further preferred, and a methyl or ethyl group is particularly preferred.

[0107] The alkoxy group is preferably an alkoxy group having 1 to 18 carbon atoms, more preferably an alkoxy group having 1 to 8 carbon atoms (e.g., methoxy, ethoxy, n-butoxy, methoxyethoxy), further preferably an alkoxy group having 1 to 4 carbon atoms, and particularly preferably a methoxy or ethoxy group.

[0108] Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. Among them, a fluorine atom and a chlorine atom are preferred.

[0109] In the present invention, G 1 Preferably it is a 1,4-cyclohexylene group which may have a substituent.

[0110] Furthermore, since the tilt angle of the liquid crystal molecules can be further reduced, G 1 An aromatic ring which may have a substituent is preferred.

[0111] In the above formula (I), Cy 1 represents a 1,4-cyclohexylene group which may have a substituent. 1 The substituents that may be present are the same as the group.

[0112] In the above formula (I), A 1 The aromatic ring represented by may be the same as the above G 1 The same group as the aromatic ring represented by one embodiment of .

[0113] And, about A 1 As the substituent that the aromatic ring may have, there can be mentioned the same substituent as the above G 1 The substituents that may be present are the same as the group.

[0114] In the above formula (I), A 2 It represents an aromatic ring or a cyclohexane ring which may have a substituent R, and is preferably an aromatic ring which may have a substituent R, and more preferably a benzene ring which may have a substituent R, because the tilt angle of the liquid crystal molecules can be further reduced.

[0115] Here, as A 2 The aromatic ring represented by one embodiment of the present invention includes the following: 1 In addition, when A 2When it is a 6-membered aromatic ring, relative to X 3 The bonding position of has no substituent R in the para position.

[0116] And, as mentioned above, A 2 The substituent R that the aromatic ring represented by one embodiment may have represents a linear or branched alkoxy group having 1 to 11 carbon atoms, a linear or branched alkyl group having 1 to 12 carbon atoms, or -Z-Sp-P. In addition, Z and Sp are the same as the above groups, and P will be described later.

[0117] Here, specific examples of the linear or branched alkoxy group having 1 to 11 carbon atoms include methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, and decyloxy groups.

[0118] Specific examples of the linear or branched alkyl group having 1 to 12 carbon atoms include methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, and cyclohexyl.

[0119] Among these substituents R, -Z-Sp-P is preferred because the durability of the cured product of the present invention described later is improved. In addition, when the substituent R is -Z-Sp-P, two Z, Sp, and P in formula (I) may be the same or different.

[0120] In the present invention, A 2 Preferably relative to X 3 The bonding position is a 6-membered aromatic ring having a substituent R at the ortho or meta position.

[0121] And, A 2 An unsubstituted 6-membered aromatic ring is preferred.

[0122] In the above formula (I), n represents 0 or 1, m represents an integer of 0 to 2, and n+m represents an integer of 1 to 3. When m is 2, there are two X in the formula. 2 and A 1 They may be the same as or different from each other.

[0123] In the present invention, the total of n and m is preferably 1 or 2, and more preferably 1, because the tilt angle of the liquid crystal molecules can be further reduced.

[0124] Furthermore, m is preferably 0 or 1, and more preferably 0, because the tilt angle of the liquid crystal molecules can be further reduced.

[0125] Furthermore, n is preferably 0 or 1 because the tilt angle of the liquid crystal molecules can be further reduced.

[0126] In the above formula (I), P represents a polymerizable group. 2 In the case of an aromatic ring having -Z-Sp-P as a substituent R, one of two Ps present in the formula represents a polymerizable group, and the other represents a hydrogen atom or a polymerizable group.

[0127] Here, as the polymerizable group, a polymerizable group capable of radical polymerization or cation polymerization is preferred.

[0128] As the free radical polymerizable group, a well-known free radical polymerizable group can be used, and as a preferred free radical polymerizable group, an acryloyloxy group or a methacryloyloxy group can be mentioned. It is known that in this case, the polymerization speed of the acryloyloxy group is usually fast, and from the viewpoint of improving productivity, the acryloyloxy group is preferred, but the methacryloyloxy group can also be used as the polymerizable group in the same manner.

[0129] As the cationically polymerizable group, well-known cationically polymerizable groups can be used, and specifically, alicyclic ether groups, cyclic acetal groups, cyclic lactone groups, cyclic thioether groups, spirocyclic orthoester groups, and vinyloxy groups can be mentioned. Among them, alicyclic ether groups or vinyloxy groups are preferred, and epoxy groups, oxetanyl groups, or vinyloxy groups are particularly preferred.

[0130] In the present invention, the polymerizable group is preferably a polymerizable group represented by any one of the following formulae (P-1) to (P-9).

[0131] [Chemical formula 2]

[0132]

[0133] Specific preferred examples of compound (I) include the following compounds.

[0134] [Chemical formula 3]

[0135]

[0136] [Chemical formula 4]

[0137]

[0138] [Chemical formula 5]

[0139]

[0140] [Chemical formula 6]

[0141]

[0142] [Chemical formula 7]

[0143]

[0144] [Chemical formula 8]

[0145]

[0146] [Chemical formula 9]

[0147]

[0148] [Chemical formula 10]

[0149]

[0150] [Chemical formula 11]

[0151]

[0152] [Chemical formula 12]

[0153]

[0154] [Chemical formula 13]

[0155]

[0156] [Chemical formula 14]

[0157]

[0158] [Chemical formula 15]

[0159]

[0160] The synthesis method of compound (I) is not particularly limited, and a common synthesis method can be used. For example, in the case of an esterification reaction, examples include acid chlorination, tosylation, benzenesulfonylation, mesylation, and a method using a condensing agent using an alcohol as a raw material, and in the case of an amidation reaction, examples include a method using an amine as a raw material instead of an alcohol.

[0161] Examples of the solvent used for the reaction or post-treatment and purification include ester solvents such as methyl acetate, ethyl acetate, and butyl acetate; ether solvents such as tetrahydrofuran, dioxane, and diethyl ether; hydrocarbon solvents such as toluene, xylene, n-hexane, n-heptane, and cyclohexane; halogen solvents such as dichloromethane and chloroform; alcohol solvents such as methanol, ethanol, and isopropanol; water; and other general solvents.

[0162] Examples of the base used in the reaction include triethylamine, diisopropylethylamine, pyridine, dimethylaminopyridine, and N-methylimidazole.

[0163] As a post-treatment step, separation and purification can be carried out by a common method such as liquid separation, crystallization, recrystallization, or silica gel column chromatography.

[0164] During liquid separation and purification, as a method for removing impurities, separation and purification can be performed using hydrochloric acid water, sodium bicarbonate aqueous solution, saline water, etc.

[0165] During crystallization and purification, the general-purpose solvents described above can be used for separation and purification.

[0166] [Polymerizable composition]

[0167] The polymerizable composition of the present invention is a polymerizable composition containing the above-mentioned compound (I).

[0168] 〔Polymerizable liquid crystal compound〕

[0169] The polymerizable composition of the present invention preferably contains a polymerizable liquid crystal compound different from the above-mentioned compound (I).

[0170] Here, the polymerizable liquid crystal compound refers to a liquid crystal compound having a polymerizable group.

[0171] Generally, liquid crystal compounds can be classified into rod-shaped and disc-shaped types according to their shapes. Moreover, they have low molecular weight and high molecular weight types. High molecular weight generally refers to a polymer with a degree of polymerization of 100 or more (Polymer Physics and Phase Transition Dynamics, written by Masao Doi, page 2, Iwanami Shoten, 1992).

[0172] In the present invention, any liquid crystal compound can be used, but a rod-like liquid crystal compound or a discotic liquid crystal compound is preferably used, and a rod-like liquid crystal compound is more preferably used.

[0173] In the present invention, from the viewpoint of fixing the liquid crystal compound, the polymerizable liquid crystal compound preferably has two or more polymerizable groups in one molecule.

[0174] The type of polymerizable group is not particularly limited, and is preferably a functional group capable of addition polymerization, preferably a polymerizable ethylenically unsaturated group or a cyclopolymerizable group. More specifically, preferably acryloyl, methacryloyl, vinyl, styryl, allyl, etc., more preferably acryloyl and methacryloyl.

[0175] Among these polymerizable groups, the polymerizable group possessed by the polymerizable liquid crystal compound is preferably a polymerizable group different from the polymerizable group possessed by the above-mentioned compound (I) because the tilt angle of the liquid crystal molecules can be further reduced.

[0176] As rod-like liquid crystal compounds, for example, compounds described in claim 1 of Japanese Patent Publication No. 11-513019 or in paragraphs

[0026] to

[0098] of Japanese Patent Publication No. 2005-289980 can be preferably used. As discotic liquid crystal compounds, for example, compounds described in paragraphs

[0020] to

[0067] of Japanese Patent Publication No. 2007-108732 and in paragraphs

[0013] to

[0108] of Japanese Patent Publication No. 2010-244038 can be preferably used, but are not limited to these.

[0177] In the present invention, it is preferable to use a polymerizable smectic liquid crystal compound as the polymerizable liquid crystal compound.

[0178] Here, the “polymerizable smectic liquid crystal compound” is a compound having a polymerizable group and exhibiting a liquid crystal state of a smectic phase.

[0179] The liquid crystal state represented by the polymerizable smectic liquid crystal compound is preferably a high-order smectic phase. The high-order smectic phase described herein is a smectic A phase, a smectic B phase, a smectic D phase, a smectic E phase, a smectic F phase, a smectic G phase, a smectic H phase, a smectic I phase, a smectic J phase, a smectic K phase, and a smectic L phase, among which the smectic A phase, the smectic B phase, the smectic F phase, the smectic I phase, the tilted smectic F phase, and the tilted smectic I phase are preferred, and the smectic A phase and the smectic B phase are more preferred.

[0180] Examples of such polymerizable smectic liquid crystal compounds include compounds described in paragraphs

[0043] to

[0055] of JP-A-2013-033249.

[0181] Furthermore, in the present invention, as the polymerizable liquid crystal compound, a reverse wavelength dispersion liquid crystal compound can be used.

[0182] Here, in this specification, a "reverse wavelength dispersion" liquid crystal compound means that when the in-plane retardation (Re) value of a phase difference film produced using the compound is measured at a specific wavelength (visible light range), the Re value remains the same or increases as the measured wavelength increases.

[0183] Furthermore, the reverse wavelength dispersive liquid crystal compound is not particularly limited as long as it is a compound that can form a reverse wavelength dispersive film as described above. For example, the compound represented by the general formula (I) described in Japanese Patent Publication No. 2008-297210 (especially the compounds described in paragraphs

[0034] to

[0039] ), the compound represented by the general formula (1) described in Japanese Patent Publication No. 2010-084032 (especially the compounds described in paragraphs

[0067] to

[0073] ), the compound represented by the general formula (II) described in Japanese Patent Publication No. 2016-053709 (especially the compounds described in paragraphs

[0036] to

[0043] ), and the compound represented by the general formula (1) described in Japanese Patent Publication No. 2016-081035 (especially the compounds described in paragraphs

[0043] to

[0055] ) can be used.

[0184] Furthermore, from the perspective of improving reverse wavelength dispersion, the above-mentioned polymerizable liquid crystal compounds may preferably include compounds represented by the following formulae (1) to (22). Specifically, as K (side chain structure) in the following formulae (1) to (22), compounds having side chain structures shown in the following Tables 1 to 3 may be included, respectively.

[0185] In addition, in the following Tables 1 to 3, "*" shown in the side chain structure of K indicates the bonding position to the aromatic ring.

[0186] In the side chain structures represented by 1-2 in Table 2 and 2-2 in Table 3, the groups adjacent to the acryloyloxy group and the methacryloyl group are propylene groups (groups in which methyl groups are substituted with ethylene groups), and are mixtures of positional isomers in which the positions of methyl groups are different.

[0187] [Chemical formula 16]

[0188]

[0189] [Table 1]

[0190]

[0191] [Table 2]

[0192]

[0193] [Table 3]

[0194]

[0195] Furthermore, in the present invention, as the polymerizable liquid crystal compound, a positive wavelength dispersion liquid crystal compound can be used, and in particular, it is preferable to use the positive wavelength dispersion liquid crystal compound together with the reverse wavelength dispersion liquid crystal compound.

[0196] Here, in this specification, a “positive wavelength dispersion” liquid crystal compound means that when the in-plane retardation (Re) value of a retardation film produced using the compound is measured at a specific wavelength (visible light range), the Re value decreases as the measured wavelength increases.

[0197] As positive wavelength dispersion liquid crystal compounds, for example, preferably, compounds represented by the following formulae (30) to (53) can be cited. Specifically, as K (side chain structure) in the following formulae (30) to (53), compounds having side chain structures shown in Tables 2 and 3 above can be cited respectively.

[0198] In Tables 2 and 3 above, the "*" shown in the side chain structure of K indicates the bonding position to the benzene ring, piperazine ring or cyclohexane ring in the following formulae (30) to (53).

[0199] In the side chain structures represented by 1-2 in Table 2 and 2-2 in Table 3, the groups adjacent to the acryloyloxy group and the methacryloyl group are propylene groups (groups in which methyl groups are substituted with ethylene groups), and are mixtures of positional isomers in which the positions of the methyl groups are different.

[0200] [Chemical formula 17]

[0201]

[0202] 〔Polymerization initiator〕

[0203] The polymerizable composition of the present invention preferably contains a polymerization initiator.

[0204] The polymerization initiator used is preferably a photopolymerization initiator capable of initiating a polymerization reaction by ultraviolet irradiation.

[0205] Examples of the photopolymerization initiator include α-carbonyl compounds (described in U.S. Pat. No. 2,367,661 and U.S. Pat. No. 2,367,670), acyloin ethers (described in U.S. Pat. No. 2,448,828), α-hydrocarbon-substituted aromatic acyloin compounds (described in U.S. Pat. No. 2,722,512), polynuclear quinone compounds (described in U.S. Pat. No. 3,046,127 and U.S. Pat. No. 2,951,758), triaryl imidazole dimers, and p-aminophenyl ketones. combinations (described in U.S. Patent No. 3549367), acridine and phenazine compounds (described in Japanese Patent Publication No. 60-105667, U.S. Patent No. 4239850) and oxadiazole compounds (described in U.S. Patent No. 4212970), acylphosphine oxide compounds (described in Japanese Patent Publication No. 63-40799, Japanese Patent Publication No. 5-29234, Japanese Patent Publication No. 10-95788, Japanese Patent Publication No. 10-29997), etc.

[0206] Furthermore, in the present invention, the polymerization initiator is preferably an oxime-type polymerization initiator, and specific examples thereof include the initiators described in paragraphs

[0049] to

[0052] of International Publication No. 2017 / 170443.

[0207] 〔Solvent〕

[0208] The polymerizable composition of the present invention preferably contains a solvent from the viewpoint of workability in forming a cured product of the present invention (for example, an optically anisotropic layer) described later.

[0209] Specific examples of the solvent include ketones (e.g., acetone, 2-butanone, methyl isobutyl ketone, cyclohexanone, cyclopentanone, etc.), ethers (e.g., dioxane, tetrahydrofuran, etc.), aliphatic hydrocarbons (e.g., hexane, etc.), alicyclic hydrocarbons (e.g., cyclohexane, etc.), aromatic hydrocarbons (e.g., toluene, xylene, trimethylbenzene, etc.), halogenated carbons (e.g., dichloromethane, dichloroethane, dichlorobenzene, chlorotoluene, etc.), esters (e.g., methyl acetate, ethyl acetate, butyl acetate, etc.), water, alcohols (e.g., ethanol, isopropanol, butanol, cyclohexanol, etc.), cellosolves (e.g., methyl cellosolve, ethyl cellosolve, etc.), cellosolve acetates, sulfoxides (e.g., dimethyl sulfoxide, etc.), amides (e.g., dimethylformamide, dimethylacetamide, etc.), and the like. Any one of these may be used alone, or two or more of them may be used simultaneously.

[0210] 〔Leveling agent〕

[0211] The polymerizable composition of the present invention preferably contains a leveling agent from the viewpoint of maintaining the surface of the cured product of the present invention described later smooth and facilitating orientation control.

[0212] As such a leveling agent, a fluorine-based leveling agent or a silicone-based leveling agent is preferred because of its high leveling effect relative to the amount added, and a fluorine-based leveling agent is more preferred because it is less likely to cause bleeding (blooming, leakage).

[0213] Specific examples of the leveling agent include compounds described in paragraphs

[0079] to

[0102] of JP-A-2007-069471, compounds represented by the general formula (I) described in JP-A-2013-047204 (particularly, compounds described in paragraphs

[0020] to

[0032] ), and compounds represented by the general formula (I) described in JP-A-2012-211306 (particularly, compounds described in paragraphs

[0022] to

[0033] ). 29]), liquid crystal alignment promoters represented by general formula (I) described in Japanese Patent Publication No. 2002-129162 (especially, compounds described in paragraphs

[0076] to

[0078] and

[0082] to

[0084] ), compounds represented by general formulas (I), (II) and (III) described in Japanese Patent Publication No. 2005-099248 (especially, compounds described in paragraphs

[0092] to

[0096] ), etc. In addition, it can also function as an alignment control agent described later.

[0214] 〔Orientation control agent〕

[0215] The polymerizable composition of the present invention may contain an alignment control agent as necessary.

[0216] The alignment control agent can form various alignment states such as vertical alignment, inclined alignment, hybrid alignment, and cholesteric alignment in addition to uniform alignment, and can more uniformly and precisely control and realize a specific alignment state.

[0217] As the orientation control agent that promotes uniform orientation, for example, a low-molecular orientation control agent or a high-molecular orientation control agent can be used.

[0218] As low molecular weight alignment control agents, for example, reference can be made to the descriptions in paragraphs

[0009] to

[0083] of Japanese Patent Application Laid-Open No. 2002-20363, paragraphs

[0111] to

[0120] of Japanese Patent Application Laid-Open No. 2006-106662, and paragraphs

[0021] to

[0029] of Japanese Patent Application Laid-Open No. 2012-211306, and these contents are incorporated into the present specification.

[0219] As polymer orientation control agents, for example, paragraphs

[0021] to

[0057] of Japanese Patent Application Laid-Open No. 2004-198511 and paragraphs

[0121] to

[0167] of Japanese Patent Application Laid-Open No. 2006-106662 can be referred to, and the contents are incorporated into the present specification.

[0220] Furthermore, as orientation control agents for forming or promoting vertical orientation, for example, boric acid compounds and onium salt compounds can be cited. Specifically, reference can be made to the compounds described in paragraphs

[0023] to

[0032] of Japanese Patent Publication No. 2008-225281, paragraphs

[0052] to

[0058] of Japanese Patent Publication No. 2012-208397, paragraphs

[0024] to

[0055] of Japanese Patent Publication No. 2008-026730, and paragraphs

[0043] to

[0055] of Japanese Patent Publication No. 2016-193869, and the like, and the contents are incorporated into the specification of the present application.

[0221] On the other hand, cholesteric alignment can be achieved by adding a chiral agent to the composition of the present invention, and the rotation direction of the cholesteric alignment can be controlled according to the chiral direction of the chiral agent.

[0222] In addition, the pitch of the cholesteric orientation can be controlled by the orientation regulating force of the chiral agent.

[0223] The content of the orientation control agent is preferably 0.01 to 10% by mass, more preferably 0.05 to 5% by mass, relative to the total solid content in the composition. If the content is within this range, a uniform and highly transparent cured product can be obtained that achieves the desired orientation state without precipitation, phase separation, orientation defects, etc.

[0224] These alignment control agents can also provide a polymerizable functional group, and in particular, can provide a polymerizable functional group that can polymerize with the compound (I) contained in the composition of the present invention.

[0225] [Other ingredients]

[0226] The polymerizable composition of the present invention may further contain components other than the above components, for example, a surfactant, a tilt angle control agent, an alignment aid, a plasticizer, a crosslinking agent, and the like.

[0227] [cured material]

[0228] The cured product of the present invention is a cured product obtained by curing the polymerizable composition of the present invention described above.

[0229] Here, when the polymerizable composition of the present invention contains a polymerizable liquid crystal compound different from compound (I) together with compound (I), the polymerizable composition of the present invention can be polymerized to form an optically anisotropic layer as a cured product.

[0230] Examples of a method for forming a cured product include a method in which the polymerizable composition of the present invention is used to form a desired oriented state and then fixed by polymerization.

[0231] Here, the polymerization conditions are not particularly limited, but in the polymerization by light irradiation, ultraviolet rays are preferably used. The irradiation dose is preferably 10 mJ / cm 2 ~50J / cm 2 , more preferably 20 mJ / cm 2 ~5J / cm 2 , more preferably 30 mJ / cm 2 ~3J / cm 2 , especially preferably 50 to 1000 mJ / cm 2 Furthermore, in order to promote the polymerization reaction, it may be carried out under heating conditions.

[0232] In the present invention, the cured product can be formed on any support in the optical film of the present invention described below or on a polarizer in the polarizing plate of the present invention described below.

[0233] The cured product of the present invention is preferably an optically anisotropic layer satisfying the following formula (II).

[0234] 0.50<Re(450) / Re(550)<1.00……(II)

[0235] In the above formula (II), Re(450) represents the in-plane retardation of the optical anisotropic layer at a wavelength of 450 nm, and Re(550) represents the in-plane retardation of the optical anisotropic layer at a wavelength of 550 nm. In addition, in this specification, when the measurement wavelength of the retardation is not specified, the measurement wavelength is set to 550 nm.

[0236] The values ​​of in-plane retardation and thickness-direction retardation are values ​​measured using AxoScan OPMF-1 (manufactured by Opto Science, Inc.) using light of a measurement wavelength.

[0237] Specifically, the average refractive index ((Nx+Ny+Nz) / 3) and film thickness (d (μm)) were input into AxoScan OPMF-1 to calculate

[0238] Slow axis direction (°)

[0239] Re(λ)=R0(λ)

[0240] Rth(λ)=((nx+ny) / 2-nz)×d.

[0241] In addition, R0(λ) is shown as a value calculated using AxoScan OPMF-1, but refers to Re(λ).

[0242] Furthermore, such an optically anisotropic layer is preferably a positive A plate or a positive C plate, and more preferably a positive A plate.

[0243] Here, a positive A plate and a positive C plate are defined as follows.

[0244] When the refractive index in the slow axis direction (the direction with the largest refractive index in the plane) of the film is set to nx, the refractive index in the direction orthogonal to the slow axis in the plane is set to ny, and the refractive index in the thickness direction is set to nz, the positive A plate satisfies the relationship of formula (A1), and the positive C plate satisfies the relationship of formula (C1). In addition, the Rth of the positive A plate is a positive value, and the Rth of the positive C plate is a negative value.

[0245] Formula (A1)nx>ny≈nz

[0246] Formula (C1)nz>nx≈ny

[0247] In addition, the above-mentioned “≈” includes not only the case where the two are completely identical, but also the case where the two are substantially identical.

[0248] The term "substantially the same" means that, in a positive A plate, for example, even when (ny-nz)×d (where d is the thickness of the thin film) is -10 to 10 nm, preferably -5 to 5 nm, it is included in "ny≈nz", and even when (nx-nz)×d is -10 to 10 nm, preferably -5 to 5 nm, it is included in "nx≈nz". Furthermore, in a positive C plate, for example, even when (nx-ny)×d (where d is the thickness of the thin film) is 0 to 10 nm, preferably 0 to 5 nm, it is included in "nx≈ny".

[0249] When the optically anisotropic layer is a positive A plate, Re(550) is preferably 100 to 180 nm, more preferably 120 to 160 nm, further preferably 130 to 150 nm, and particularly preferably 130 to 140 nm from the viewpoint of functioning as a λ / 4 plate.

[0250] Here, the “λ / 4 plate” refers to a plate having a λ / 4 function, and specifically, refers to a plate having a function of converting linearly polarized light of a certain wavelength into circularly polarized light (or converting circularly polarized light into linearly polarized light).

[0251] [Optical film]

[0252] The optical film of the present invention is an optical film having the cured product of the present invention.

[0253] Figure 1A , Figure 1B and Figure 1C (Hereinafter, when there is no need to particularly distinguish these drawings, they are simply referred to as “ FIG. 1 .”) Each of these drawings is a schematic cross-sectional view showing an example of the optical film of the present invention.

[0254] 1 is a schematic diagram, and the relationship between the thickness and position of each layer is not necessarily consistent with the actual relationship. The support, alignment film and hard coat layer shown in FIG. 1 are all arbitrary components.

[0255] The optical film 10 shown in FIG. 1 includes a support 16 , an alignment film 14 , and an optically anisotropic layer 12 which is a cured product in this order.

[0256] And, if Figure 1B As shown, the optical film 10 may have a hard coating layer 18 on the side of the support 16 opposite to the side on which the alignment film 14 is disposed. Figure 1C As shown, the optically anisotropic layer 12 may have a hard coat layer 18 on the side opposite to the side on which the alignment film 14 is provided.

[0257] Hereinafter, various members used in the optical film of the present invention will be described in detail.

[0258] [Cured material]

[0259] The cured product of the optical film of the present invention is the cured product of the present invention described above.

[0260] In the optical film of the present invention, the thickness of the cured product is not particularly limited, but when used as an optically anisotropic layer, it is preferably 0.1 to 10 μm, and more preferably 0.5 to 5 μm.

[0261] 〔Support〕

[0262] As described above, the optical film of the present invention may have a support as a base material for forming a cured product.

[0263] Such a support is preferably transparent, and specifically, preferably has a light transmittance of 80% or more.

[0264] Examples of such a support include a glass substrate and a polymer film, and examples of the material for the polymer film include a cellulose polymer; an acrylic polymer having an acrylate polymer, such as polymethyl methacrylate and a polymer containing a lactone ring; a thermoplastic norbornene polymer; a polycarbonate polymer; a polyester polymer such as polyethylene terephthalate and polyethylene naphthalate; a styrene polymer such as polystyrene and acrylonitrile-styrene copolymer (AS resin); a polyolefin polymer such as polyethylene, polypropylene and ethylene-propylene copolymer; a vinyl chloride polymer; an amide polymer such as nylon and aromatic polyamide; an imide polymer; a sulfone polymer; a polyethersulfone polymer; a polyetheretherketone polymer; a polyphenylene sulfide polymer; a vinylidene chloride polymer; a vinyl alcohol polymer; a vinyl butyral polymer; an arylate polymer; a polyoxymethylene polymer; an epoxy polymer; or a polymer obtained by mixing these polymers.

[0265] Furthermore, a polarizer described later may also serve as such a support.

[0266] In the present invention, the thickness of the support is not particularly limited, but is preferably 5 to 60 μm, more preferably 5 to 30 μm.

[0267] 〔Oriented film〕

[0268] When the optical film of the present invention has any of the above-mentioned supports, it is preferred that an alignment film is provided between the support and the cured product. Alternatively, the above-mentioned support may also serve as the alignment film.

[0269] The alignment film generally contains a polymer as a main component. Polymer materials for alignment films are described in many documents, and many commercial products are available.

[0270] The polymer material used in the present invention is preferably polyvinyl alcohol or polyimide and its derivatives, and modified or unmodified polyvinyl alcohol is particularly preferred.

[0271] Regarding the alignment film that can be used in the present invention, for example, there can be cited the alignment film described in line 24 on page 43 to line 8 on page 49 of International Publication No. 01 / 88574; the modified polyvinyl alcohol described in paragraphs

[0071] to

[0095] of Japanese Patent Gazette No. 3907735; the liquid crystal alignment film formed by a liquid crystal alignment agent described in Japanese Patent Gazette No. 2012-155308, etc.

[0272] In the present invention, it is also preferable to use a photo-alignment film as the alignment film because the surface morphology can be prevented from being deteriorated by not contacting the alignment film surface when the alignment film is formed.

[0273] There is no particular limitation on the photo-alignment film, but polymer materials such as polyamide compounds and polyimide compounds described in paragraphs

[0024] to

[0043] of International Publication No. 2005 / 096041; liquid crystal alignment films formed by liquid crystal alignment agents having photo-alignment groups described in Japanese Patent Gazette No. 2012-155308; and trade name LPP-JP265CP manufactured by Rolic Technologies, etc. can be used.

[0274] Furthermore, in the present invention, the thickness of the above-mentioned oriented film is not particularly limited, but from the viewpoint of alleviating surface irregularities on the support to form an optically anisotropic layer with uniform film thickness, it is preferably 0.01 to 10 μm, more preferably 0.01 to 1 μm, and further preferably 0.01 to 0.5 μm.

[0275] 〔Hard coating〕

[0276] In order to impart physical strength to the film, the optical film of the present invention preferably has a hard coating layer. Specifically, the support may have a hard coating layer on the side opposite to the side on which the oriented film is provided (see Figure 1B ), the optically anisotropic layer may have a hard coating layer on the side opposite to the side on which the oriented film is provided (refer to Figure 1C ).

[0277] As the hard coating layer, the hard coating layers described in paragraphs

[0190] to

[0196] of Japanese Patent Application Laid-Open No. 2009-98658 can be used.

[0278] 〔Ultraviolet light absorber〕

[0279] In consideration of the influence of external light (especially, ultraviolet rays), the optical film of the present invention preferably contains an ultraviolet (UV) absorber.

[0280] The ultraviolet absorber may be contained in the cured product of the present invention, or may be contained in a member other than the cured product constituting the optical film of the present invention. As the member other than the cured product, for example, a support is preferably mentioned.

[0281] As the ultraviolet absorber, any existing known ultraviolet absorber that can show ultraviolet absorptivity can be used. Among such ultraviolet absorbers, from the viewpoint of high ultraviolet absorptivity and obtaining the ultraviolet absorptivity (ultraviolet cut-off capability) used in the image display device, preferably a benzotriazole or hydroxyphenyltriazine ultraviolet absorber is used.

[0282] Furthermore, in order to expand the absorption width of ultraviolet rays, two or more ultraviolet absorbers having different maximum absorption wavelengths may be used simultaneously.

[0283] Specific examples of the ultraviolet absorber include compounds described in paragraphs

[0258] to

[0259] of JP-A-2012-18395 and compounds described in paragraphs

[0055] to

[0105] of JP-A-2007-72163.

[0284] Furthermore, as commercially available products, Tinuvin 400, Tinuvin 405, Tinuvin 460, Tinuvin 477, Tinuvin 479, and Tinuvin 1577 (all manufactured by BASF) and the like can be used.

[0285] [Polarizing plate]

[0286] The polarizing plate of the present invention comprises the above-mentioned optical film of the present invention and a polarizer.

[0287] Furthermore, when the optically anisotropic layer as a cured product of the present invention is a λ / 4 plate (positive A plate), the polarizing plate of the present invention can be used as a circularly polarizing plate.

[0288] Furthermore, regarding the polarizer of the present invention, when the optically anisotropic layer as a cured product of the present invention is a λ / 4 plate (positive A plate), the angle formed by the slow axis of the λ / 4 plate and the absorption axis of the polarizer described later is preferably 30 to 60°, more preferably 40 to 50°, further preferably 42 to 48°, and particularly preferably 45°.

[0289] Here, the “slow axis” of the λ / 4 plate refers to a direction in which the refractive index in the plane of the λ / 4 plate is maximum, and the “absorption axis” of the polarizer refers to a direction in which the absorbance is highest.

[0290] 〔Polarizer〕

[0291] The polarizer included in the polarizing plate of the present invention is not particularly limited as long as it has a function of converting light into specific linearly polarized light, and a conventionally known absorption-type polarizer or reflection-type polarizer can be used.

[0292] As the absorption type polarizer, an iodine polarizer, a dye polarizer using a dichroic dye, a polyene polarizer, etc. can be used. Among the iodine polarizers and dye polarizers, there are coating type polarizers and stretching type polarizers, and both can be used, but a polarizer made by adsorbing iodine or a dichroic dye on polyvinyl alcohol and stretching is preferred.

[0293] Furthermore, as a method for obtaining a polarizer by stretching and dyeing a laminated film having a polyvinyl alcohol layer formed on a substrate, Japanese Patent No. 5048120, Japanese Patent No. 5143918, Japanese Patent No. 4691205, Japanese Patent No. 4751481, and Japanese Patent No. 4751486 can be cited, and these known techniques related to polarizers can also be preferably utilized.

[0294] As the reflective polarizer, a polarizer obtained by laminating thin films having different birefringence, a wire grid polarizer, a polarizer obtained by combining cholesteric liquid crystal having a selective reflection region and a quarter wavelength plate, or the like can be used.

[0295] Among them, from the viewpoint of better adhesion, a polarizer comprising a polyvinyl alcohol-based resin (a polymer comprising -CH2-CHOH- as a repeating unit. In particular, at least one selected from the group consisting of polyvinyl alcohol and ethylene-vinyl alcohol copolymer) is preferred.

[0296] In the present invention, the thickness of the polarizer is not particularly limited, but is preferably 3 μm to 60 μm, more preferably 5 μm to 30 μm, and further preferably 5 μm to 15 μm.

[0297] [Adhesive layer]

[0298] In the polarizing plate of the present invention, a pressure-sensitive adhesive layer may be disposed between the cured product in the optical film of the present invention and the polarizer.

[0299] As an adhesive layer for laminating a cured product and a polarizer, for example, a material having a ratio of a storage modulus G' to a loss elastic modulus G" (tanδ=G" / G') measured by a dynamic viscoelasticity measuring device of 0.001 to 1.5, including so-called adhesives or materials that are prone to creep. As an adhesive that can be used in the present invention, for example, a polyvinyl alcohol-based adhesive can be cited, but it is not limited to this.

[0300] [Image display device]

[0301] The image display device of the present invention is an image display device including the optical film of the present invention or the polarizing plate of the present invention.

[0302] The display element used in the image display device of the present invention is not particularly limited, and examples thereof include a liquid crystal cell, an organic electroluminescent (hereinafter, abbreviated as "EL") display panel, and a plasma display panel.

[0303] Among these, a liquid crystal cell and an organic EL display panel are preferred, and a liquid crystal cell is more preferred. That is, as the image display device of the present invention, a liquid crystal display device using a liquid crystal cell as a display element and an organic EL display device using an organic EL display panel as a display element are preferred, and a liquid crystal display device is more preferred.

[0304] 〔Liquid crystal display device〕

[0305] A liquid crystal display device as an example of the image display device of the present invention is a liquid crystal display device including the polarizing plate of the present invention described above and a liquid crystal cell.

[0306] In the present invention, among the polarizing plates provided on both sides of the liquid crystal cell, the polarizing plate of the present invention is preferably used as the front polarizing plate, and more preferably used as the front and rear polarizing plates.

[0307] Hereinafter, the liquid crystal cell constituting the liquid crystal display device will be described in detail.

[0308] <Liquid crystal unit>

[0309] The liquid crystal cell used in the liquid crystal display device is preferably a VA (Vertical Alignment) mode, an OCB (Optically Compensated Bend) mode, an IPS (In-Plane-Switching) mode, or a TN (Twisted Nematic) mode, but is not limited thereto.

[0310] In a TN mode liquid crystal cell, rod-shaped liquid crystal molecules are substantially horizontally aligned when no voltage is applied, and further have a twisted alignment of 60 to 120°. TN mode liquid crystal cells are most commonly used as color TFT liquid crystal display devices and are described in many documents.

[0311] In a VA mode liquid crystal cell, rod-shaped liquid crystal molecules are substantially aligned vertically when no voltage is applied. VA mode liquid crystal cells include (1) a narrow VA mode liquid crystal cell in which rod-shaped liquid crystal molecules are substantially aligned vertically when no voltage is applied and are substantially aligned horizontally when a voltage is applied (described in Japanese Patent Laid-Open No. 2-176625), (2) a VA mode liquid crystal cell (described in SID97, Digest of tech. Papers 28 (1997) 845) in which a multi-domain VA mode is implemented to expand the viewing angle, (3) a liquid crystal cell in which rod-shaped liquid crystal molecules are substantially aligned vertically when no voltage is applied and are aligned in a twisted multi-domain orientation when a voltage is applied (described in Proceedings of the Japan Liquid Crystal Conference 58-59 (1998)), and (4) a SURVIVAL mode liquid crystal cell (published in LCD International 98). Furthermore, it may be any of PVA (Patterned Vertical Alignment), optical alignment, and PSA (Polymer-Sustained Alignment). Details of these modes are described in Japanese Unexamined Patent Publication No. 2006-215326 and Japanese Translation of National Publication No. 2008-538819.

[0312] Regarding the liquid crystal unit of the IPS mode, the rod-shaped liquid crystal molecules are substantially parallel to the substrate, and the liquid crystal molecules are planarly responsive by applying an electric field parallel to the substrate surface. Regarding the IPS mode, a black display is obtained when no electric field is applied, and the absorption axes of the upper and lower polarizers are orthogonal. Japanese Patent Publication No. 10-54982, Japanese Patent Publication No. 11-202323, Japanese Patent Publication No. 9-292522, Japanese Patent Publication No. 11-133408, Japanese Patent Publication No. 11-305217, Japanese Patent Publication No. 10-307291, etc. disclose methods of using an optical compensation sheet to reduce light leakage during black display in an oblique direction and improve the viewing angle.

[0313] [Organic EL display device]

[0314] The organic EL display device as an example of the image display device of the present invention preferably includes, in order from the viewing side, a polarizer, a λ / 4 plate (positive A plate) composed of the optically anisotropic layer of the present invention, and an organic EL display panel.

[0315] The organic EL display panel is a display panel composed of an organic EL element in which an organic light emitting layer (organic electroluminescent layer) is sandwiched between electrodes (cathode and anode). The structure of the organic EL display panel is not particularly limited, and a known structure can be adopted.

[0316] Example

[0317] Below, based on embodiment, the present invention is described in further detail.About the material, dosage, ratio, processing content, processing step etc. shown in the following embodiment, as long as do not depart from the purport of the present invention, then can be appropriately changed.Therefore, the scope of the present invention should not be interpreted in a restrictive manner by the embodiment shown below.

[0318] [Example 1]

[0319] According to the following synthesis scheme, compound A-1 represented by the following formula A-1 was synthesized.

[0320] [Chemical formula 18]

[0321]

[0322] (1) Synthesis of Compound 1

[0323] Acrylic acid-2-hydroxyethyl ester (50.0g, 0.431mol) and dibutylhydroxytoluene (190mg, 0.862mmol) were dissolved in ethyl acetate (250mL), triethylamine (51.0g, 0.504mol) and methanesulfonic acid chloride (50.4g, 0.440mol) were added under ice-cold conditions, and stirred at room temperature for 5 hours. Water (125mL) was added to the reaction solution, and it was extracted with ethyl acetate. The organic layer obtained by extraction was washed with saturated saline, and then sodium sulfate was added. After filtering the obtained organic layer and recovering the filtrate, dibutylhydroxytoluene (190mg, 0.862mmol) was added, and the solvent was distilled under reduced pressure, thereby obtaining compound 1 (80.9g).

[0324] (2) Synthesis of Compound 2

[0325] Compound 1 (75.6 g, 0.354 mol) and dibutylhydroxytoluene (0.78 g, 3.5 mmol) were dissolved in a mixed solvent of toluene (180 mL) and dimethylacetamide (200 mL), and dicyclohexyl-1,1'-dicarboxylic acid (90.0 g, 0.354 mol) and triethylamine (71.6 g, 0.708 mol) were added at room temperature, and stirred at 90°C for 5 hours. After the reaction solution was cooled to room temperature, a mixed solution of concentrated hydrochloric acid (23.4 g) and water (130 mL) was added, and then the temperature was raised to 45°C, and the water layer was removed. The obtained organic layer was washed with a mixed solution of sodium bicarbonate (13.5 g) and water (260 mL) and a mixed solution of sodium bicarbonate (2.7 g) and water (270 mL), and magnesium sulfate was added. The obtained organic layer was filtered through diatomaceous earth and the filtrate was recovered. Then, dibutylhydroxytoluene (0.78 g, 3.5 mmol) was added and the solvent was distilled off from the filtrate under reduced pressure. The obtained residue was dissolved in toluene (360 mL) and hexane (830 mL) was added at 40°C. The solution was cooled to 5°C while stirring and stirred for 30 minutes. The generated crystals were filtered and washed with hexane to obtain compound 2 (25.0 g).

[0326] (3) Synthesis of Compound A-1

[0327] Phenol (1.00 g, 10.6 mmol) and compound 2 (4.68 g, 13.3 mmol) were dissolved in chloroform (10 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.75 g, 14.3 mmol) and dimethylaminopyridine (64.9 mg, 0.531 mmol) were added at room temperature, and stirred for 4 hours at room temperature. The reaction solution was purified by flash column chromatography to obtain a white solid. The obtained white solid was dissolved in ethyl acetate (10 mL), and hexane (100 mL) was added. The solution was cooled to 0°C while stirring and stirred for 1 hour. The generated crystals were filtered and washed with hexane to obtain compound A-1 (0.80 g).

[0328] The following shows the obtained compound A-1 1 H-NMR (Nuclear Magnetic Resonance).

[0329] 1H-NMR (CDCl3): δ=7.36 (t, 2H), 7.23 (t, 1H), 7.04 (d, 2H), 6.43 (dd, 1H), 6.13 (dd, 1H), 5.88 (dd, 1H), 4.28-4.38 (m, 4H ), 2.41-2.52(m, 1H), 2.13-2.30(m, 3H), 1.97-2.06(m, 2H), 1.77-1.90(m, 4H), 1.33-1.66(m, 4H), 0.98-1.20(m, 6H).

[0330] [Example 2]

[0331] According to the following synthesis scheme, compound A-2 represented by the following formula A-2 was synthesized.

[0332] [Chemical formula 19]

[0333]

[0334] (1) Synthesis of Compound 3

[0335] Hydroxypropyl acrylate (50.0 g, 0.384 mol) and butylated hydroxytoluene (1.69 g, 7.67 mmol) were dissolved in ethyl acetate (250 mL), triethylamine (45.5 g, 0.450 mol) and methanesulfonic acid chloride (46.7 g, 0.407 mol) were added under ice-cold conditions, and stirred at room temperature for 2 hours. Water (125 mL) was added to the reaction solution, and it was extracted with ethyl acetate. The organic layer obtained by extraction was washed with saturated saline, and then sodium sulfate was added. After filtering the obtained organic layer and recovering the filtrate, butylated hydroxytoluene (0.34 g, 1.54 mmol) was added, and the solvent was distilled under reduced pressure to obtain compound 3 (79.3 g).

[0336] (2) Synthesis of Compound 4

[0337] Compound 3 (76.6 g, 0.368 mol) and dibutylhydroxytoluene (0.74 g, 3.4 mmol) were dissolved in a mixed solvent of toluene (170 mL) and dimethylacetamide (190 mL), and dicyclohexyl-1,1'-dicarboxylic acid (85.0 g, 0.334 mol) and triethylamine (67.6 g, 0.668 mol) were added at room temperature, and stirred at 90°C for 5 hours. After the reaction solution was cooled to room temperature, a mixed solution of concentrated hydrochloric acid (22.1 g) and water (120 mL) was added, and then the temperature was raised to 45°C, and the water layer was removed. The obtained organic layer was washed with a mixed solution of sodium bicarbonate (12.7 g) and water (240 mL), a mixed solution of sodium bicarbonate (2.5 g), and a mixed solution of sodium chloride (10 g) and water (350 mL), and magnesium sulfate was added. The obtained organic layer was filtered through diatomaceous earth and the filtrate was recovered. Then, dibutylhydroxytoluene (95.7 mg, 0.434 mmmol) was added and the solvent was distilled off from the filtrate under reduced pressure. The obtained residue was dissolved in toluene (340 mL) and hexane (630 mL) was added at 40°C. The solution was cooled to 5°C while stirring and stirred for 30 minutes. The generated crystals were filtered and washed with hexane to obtain compound 4 (31.3 g).

[0338] (3) Synthesis of Compound A-2

[0339] Phenol (1.00 g, 10.6 mmol) and compound 4 (4.87 g, 13.3 mmol) were dissolved in chloroform (10 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.75 g, 14.3 mmol) and dimethylaminopyridine (64.9 mg, 0.531 mmol) were added at room temperature, and stirred at room temperature for 4 hours. Compound 4 (4.87 g, 13.3 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.75 g, 14.3 mmol) and dimethylaminopyridine (64.9 mg, 0.531 mmol) were added to the reaction solution at room temperature, and stirred at room temperature for 4 hours. The reaction solution was purified by flash column chromatography to obtain a white solid. The obtained white solid was dissolved in chloroform (5 mL), and methanol (150 mL) was added. The solution was cooled to 0°C while stirring, and stirred for 1 hour. The generated crystals were filtered and washed with methanol to obtain compound A-2 (3.23 g).

[0340] The following shows the obtained compound A-2 1 H-NMR.

[0341] 1H-NMR (CDCl3): δ=7.37 (t, 2H), 7.23 (t, 1H), 7.04 (d, 2H), 6.41 (dd, 1H), 6.12 (dd, 1H), 5.86 (dd, 1H), 5.15-5.28 (m, 1H), 4.10-4.23(m, 2H), 2.46(tt, 1H), 2.13-2.29(m, 3H), 1.95-2.07(m, 2H), 1.22-1.61(m, 7H), 0.96-1.19(m, 6H).

[0342] [Example 3]

[0343] Compound A-3 represented by the following formula A-3 was obtained as a white solid by the same procedure as in Example 1 except that 2-methoxyphenol was used instead of phenol.

[0344] [Chemical formula 20]

[0345]

[0346] The following shows the obtained compound A-3 1 H-NMR.

[0347] 1 H-NMR (CDCl3): δ=7.18 (dt, 1H), 6.90-7.02 (m, 3H), 6.44 (d, 1H), 6.14 (dd, 1H), 5.88 (dd, 1H), 4.28-4.39 (m, 4H), 3.81 (s, 3H), 2.51 (tt, 1H), 2.12-2.31 (m, 3H), 1.95-2.07 (m, 2H), 1.77-1.92 (m, 4H), 1.34-1.63 (m, 4H), 0.97-1.20 (m, 6H).

[0348] [Example 4]

[0349] Compound A-4 represented by the following formula A-4 was obtained as a white solid by the same procedure as in Example 1 except that 2-ethoxyphenol was used instead of phenol.

[0350] [Chemical formula 21]

[0351]

[0352] The following shows the obtained compound A-4 1 H-NMR.

[0353] 1H-NMR (CDCl3): δ=7.14 (dt, 1H), 7.01 (dd, 1H), 6.87-6.95 (m, 2H), 6.44 (dd, 1H), 6.14 (dd, 1H), 5.87 (dd, 1H), 4.28-4.39 (m, 4H) ), 4.02(q, 2H), 2.50(tt, 1H), 2.15-2.31(m, 3H), 1.96-2.07(m, 2H), 1.68-1.90(m, 4H), 1.32-1.63(m, 7H), 0.97-1.18(m, 6H).

[0354] [Example 5]

[0355] According to the following synthesis scheme, compound A-5 represented by the following formula A-5 was synthesized.

[0356] [Chemical formula 22]

[0357]

[0358] (1) Synthesis of Compound 5

[0359] 2-Hydroxybenzoic acid (5.01 g, 36.3 mmol), compound 1 (7.25 g, 37.3 mmol), dibutylhydroxytoluene (0.16 g, 0.73 mmol), potassium iodide (0.30 g, 1.8 mmol) were dissolved in dimethylacetamide (25 mL), triethylamine (4.05 g, 40.0 mmol) was added at room temperature, and stirred at 60°C for 2 hours. After the reaction solution was cooled to ice, 0.5 N hydrochloric acid (100 mL) was added, and extraction was performed with ethyl acetate. The obtained organic layer was washed with water (25 mL), 1 N hydrochloric acid (25 mL), saturated sodium bicarbonate aqueous solution (25 mL), and saturated saline (25 mL) in sequence, and then sodium sulfate was added. After filtering the obtained organic layer and recovering the filtrate, dibutylhydroxytoluene (0.16 g, 0.73 mmol) was added, and the solvent was distilled off from the filtrate under reduced pressure. The obtained residue was purified by flash column chromatography to obtain Compound 5 (6.55 g).

[0360] (2) Synthesis of Compound A-5

[0361] Compound 5 (1.00 g, 4.23 mmol) and compound 1 (4.68 g, 5.28 mmol) were dissolved in chloroform (10 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.10 g, 5.74 mmol) and dimethylaminopyridine (25.2 mg, 0.206 mmol) were added at room temperature, and stirred at room temperature for 3 hours. Compound 1 (2.34 g, 2.64 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.55 g, 2.9 mmol) and dimethylaminopyridine (12.6 mg, 0.103 mmol) were added to the reaction solution at room temperature, and stirred at room temperature for 3 hours. The reaction solution was purified by flash column chromatography to obtain a white solid. The obtained white solid was dissolved in ethyl acetate (2 mL), and hexane (40 mL) was added. The solution was cooled to 0°C while stirring, and stirred for 1 hour. The generated crystals were filtered and washed with hexane to obtain compound A-5 (1.31 g).

[0362] The following shows the obtained compound A-5 1 H-NMR.

[0363] 1 H-NMR (CDCl3): δ=7.99 (dd, 1H), 7.53 (dt, 1H), 7.33 (t, 1H), 7.04 (d, 1H), 6.43 (dd, 1H), 6.42 (dd, 1H), 6.14 (dd, 1H), 6.13 (dd, 1H), 5.89 (dd, 2H), 4 .42-4.52(m, 4H), 4.28-4.38(m, 4H), 2.53(t, 1H), 2.17-2.31(m, 3H), 1.9 6-2.07 (m, 2H), 1.76-1.90 (m, 4H), 1.33-1.66 (m, 4H), 0.98-1.20 (m, 6H).

[0364] [Example 6]

[0365] Compound A-6 represented by the following formula A-6 was obtained as a white solid by the same procedure as in Example 1 except that 3-methoxyphenol was used instead of phenol.

[0366] [Chemical formula 23]

[0367]

[0368] The following shows the obtained compound A-6 1 H-NMR.

[0369] 1H-NMR (CDCl3): δ=7.26 (t, 1H), 6.78 (dd, 1H), 6.60-6.68 (m, 2H), 6.43 (dd, 1H), 6.16 (dd, 1H), 5.87 (dd, 1H), 4.29-4.39 (m, 4H ), 3.78 (s, 3H), 2.46 (tt, 1H), 2.12-2.31 (m, 3H), 1.96-2.07 (m, 2H), 1.77-1.91 (m, 4H), 1.35-1.61 (m, 4H), 0.96-1.19 (m, 6H).

[0370] [Example 7]

[0371] According to the following synthesis scheme, compound A-7 represented by the following formula A-7 was synthesized.

[0372] [Chemical formula 24]

[0373]

[0374] (1) Synthesis of Compound 6

[0375] 4-Hydroxybutyl acrylate (50.0g, 0.347mol) and butylated hydroxytoluene (190mg, 0.862mmol) were dissolved in ethyl acetate (250mL), triethylamine (41.1g, 0.406mol) and methanesulfonic acid chloride (41.1g, 0.406mol) were added under ice-cold conditions, and stirred at room temperature for 5 hours. Water (125mL) was added to the reaction solution, and it was extracted with ethyl acetate. The organic layer obtained by extraction was washed with saturated saline, and then sodium sulfate was added. After filtering the obtained organic layer and recovering the filtrate, butylated hydroxytoluene (190mg, 0.862mmol) was added, and the solvent was distilled under reduced pressure, thereby obtaining compound 1 (73.7g).

[0376] (2) Synthesis of Compound 7

[0377] Compound 6 (86.5 g, 0.389 mol) and dibutylhydroxytoluene (0.78 g, 3.5 mmol) were dissolved in a mixed solvent of toluene (180 mL) and dimethylacetamide (200 mL), and dicyclohexyl-1,1'-dicarboxylic acid (90.0 g, 0.354 mol) and triethylamine (71.6 g, 0.708 mol) were added at room temperature, and stirred at 90°C for 5 hours. After the reaction solution was cooled to room temperature, a mixed solution of concentrated hydrochloric acid (23.4 g) and water (130 mL) was added, and then the temperature was raised to 45°C, and the water layer was removed. The obtained organic layer was washed with a mixed solution of sodium bicarbonate (13.5 g) and water (260 mL) and a mixed solution of sodium bicarbonate (2.7 g) and water (270 mL), and magnesium sulfate was added. The obtained organic layer was filtered through diatomaceous earth and the filtrate was recovered. Then, dibutylhydroxytoluene (0.78 g, 3.5 mmol) was added and the solvent was distilled off from the filtrate under reduced pressure. The obtained residue was dissolved in toluene (360 mL) and hexane (830 mL) was added at 40°C. The solution was cooled to 5°C while stirring and stirred for 30 minutes. The generated crystals were filtered and washed with hexane to obtain compound 7 (28.4 g).

[0378] (3) Synthesis of Compound A-7

[0379] Phenol (1.00 g, 10.6 mmol) and compound 6 (5.06 g, 13.3 mmol) were dissolved in chloroform (10 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.75 g, 14.3 mmol) and dimethylaminopyridine (64.9 mg, 0.531 mmol) were added at room temperature, and stirred for 4 hours at room temperature. The reaction solution was purified by flash column chromatography to obtain a white solid. The obtained white solid was dissolved in ethyl acetate (10 mL), and hexane (100 mL) was added. The solution was cooled to 0°C while stirring and stirred for 1 hour. The generated crystals were filtered and washed with hexane to obtain compound A-1 (3.48 g).

[0380] The following shows the obtained compound A-7 1 H-NMR.

[0381] 1H-NMR (CDCl3): δ=7.36 (t, 2H), 7.24 (t, 1H), 7.06 (d, 2H), 6.42 (dd, 1H), 6.12 (dd, 1H), 5.83 (dd, 1H), 4.14 (dt, 4H) ), 2.44(tt, 1H), 2.12-2.29(m, 3H), 1.95-2.06(m, 2H), 1.63-1.92(m, 8H), 1.25-1.64(m, 4H), 0.97-1.21(m, 6H).

[0382] [Example 8]

[0383] Compound A-8 represented by the following formula A-8 was obtained as a white solid by the same procedure as in Example 7 except that Compound 5 was used in place of phenol.

[0384] [Chemical formula 25]

[0385]

[0386] The following shows the obtained compound A-8 1 H-NMR.

[0387] 1 H-NMR (CDCl3): δ=7.99 (dd, 1H), 7.65 (dt, 1H), 7.33 (dt, 2H), 7.09 (dd, 1H), 6.44(dd, 1H), 6.43(dd, 1H), 6.16(dd, 1H), 6.15(dd, 1H), 5.87(dd, 1H), 5.86 (dd, 1H), 4.44-4.52 (m, 4H), 4.14 (dt, 4H), 2.53 (tt, 1H), 2.17-2.29 (m, 3H), 1.96-2.06(m, 2H), 1.69-1.92(m, 8H), 1.25-1.64(m, 4H), 0.96-1.20(m, 6H).

[0388] [Example 9]

[0389] Compound A-9 represented by the following formula A-9 was obtained as a white solid by the same procedure as in Example 7 except that 1-naphthol was used instead of phenol.

[0390] [Chemical formula 26]

[0391]

[0392] The following shows the obtained compound A-9 1 H-NMR.

[0393] 1 H-NMR (CDCl3): δ=7.81-7.89 (m, 2H), 7.72 (d, 1H), 7.42-7.53 (m, 3H), 7.22 (dd, 1H), 6.42 (dd, 1H), 6.12 (dd, 1H), 5.83 ( dd, 1H), 4.05-4.24(m, 4H), 2.65(tt, 1H), 2.14-2.38(m, 3H), 1.59-2.04(m, 10H), 1.28-1.50(m, 4H), 0.93-1.28(m, 6H).

[0394] [Example 10]

[0395] According to the following synthesis scheme, compound A-10 represented by the following formula A-10 was synthesized.

[0396] [Chemical formula 27]

[0397]

[0398] (1) Synthesis of Compound 8

[0399] 1,4-cyclohexyldicarboxylic acid dichloride (31.4 g, 0.150 mol) and dibutylhydroxytoluene (1.1 g, 5.0 mmol) were dissolved in ethyl acetate (160 mL), triethylamine (12.1 g, 0.120 mol) and 2-hydroxyethyl acrylate (11.6 g, 0.100 mol) were added under ice cooling, and stirred at room temperature for 3 hours. A mixed solution of sodium bicarbonate (12.2 g) and water (120 mL) and 1-methylimidazole (8.0 g, 0.098 mol) were added to the reaction solution, and after stirring at 40°C for 1 hour, the water layer was removed. The obtained organic layer was washed with 0.1N hydrochloric acid (160 mL) and 5% saline (160 mL) in sequence, and magnesium sulfate was added. The obtained organic layer was filtered through diatomaceous earth and the filtrate was recovered, and then dibutylhydroxytoluene (1.1 g, 5.0 mmol) was added, and the solvent was distilled off from the filtrate under reduced pressure. The obtained residue was dissolved in acetonitrile (310 mL), and tert-butylamine (5.78 g, 0.079 mol) was added under ice cooling. The solution was stirred for 1 hour, and the generated crystals were filtered and washed with acetonitrile.

[0400] Next, toluene (25 mL) and water (20 mL) were added to 10.0 g of the obtained crystals, and a mixed solution of concentrated hydrochloric acid (3.3 g) and water (0.3 mL) was added under ice-cold conditions. After stirring at room temperature for 30 minutes, the water layer was removed. The obtained organic layer was washed with water (50 mL) and magnesium sulfate was added. After the obtained organic layer was filtered through diatomaceous earth and the filtrate was recovered, butylated hydroxytoluene (111 mg, 0.504 mmol) was added, and the solvent was distilled under reduced pressure from the filtrate to obtain compound 8 (7.25 g).

[0401] (2) Synthesis of A-10

[0402] 4-Phenylphenol (1.34 g, 7.87 mmol) and compound 8 (2.66 g, 9.85 mmol) were dissolved in chloroform (10 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.05 g, 10.7 mmol) and dimethylaminopyridine (48.1 mg, 0.394 mmol) were added at room temperature, and stirred for 4 hours at room temperature. The reaction solution was purified by flash column chromatography to obtain a white solid. The obtained white solid was dissolved in ethyl acetate (4 mL), and hexane (80 mL) was added. The solution was cooled to 0°C while stirring and stirred for 1 hour. The generated crystals were filtered and washed with hexane to obtain compound A-10 (0.66 g).

[0403] The following shows the obtained compound A-10 1 H-NMR.

[0404] 1 H-NMR (CDCl3): δ=7.56 (t, 4H), 7.43 (t, 2H), 7.31-7.38 (m, 1H), 7.13 (d, 2H), 6.44 (dd, 1H), 6.15 (dd, 1H ), 5.88(dd, 1H), 4.33-4.41(m, 4H), 2.56(tt, 1H), 2.38(tt, 1H), 2.10-2.30(m, 4H), 1.48-1.61(m, 4H).

[0405] [Example 11]

[0406] Compound A-11 represented by the following formula A-11 was obtained as a white solid by the same procedure as in Example 10 except that 4-cyclohexylphenol was used instead of 4-phenylphenol.

[0407] [Chemical formula 28]

[0408]

[0409] The following shows the obtained compound A-11 1 H-NMR.

[0410] 1 H-NMR (CDCl3): δ=7.19 (d, 2H), 6.96 (d, 2H), 6.42 (dd, 1H), 6.13 (dd, 1H), 5.83 (dd, 1H), 4.08-4.25(m, 4H), 2.43-2.59(m, 2H), 2.03-2.40(m, 6H), 1.15-1.92(m, 13H).

[0411] [Example 12]

[0412] Compound A-12 represented by the following formula A-12 was obtained as a white solid by the same procedure as in Example 7 except that 4-phenylphenol was used instead of phenol.

[0413] [Chemical formula 29]

[0414]

[0415] The following shows the obtained compound A-12 1 H-NMR.

[0416] 1 H-NMR (CDCl3): δ = 7.52-7.62 (m, 4H), 7.43 (t, 2H), 7.34 (tt, 1H), 7.13 (d, 2H), 6.41 (dd, 1H), 6.12 (dd, 1H), 5.82 (dd, 1H), 4 .13(dt, 4H), 2.48(tt, 1H), 2.13-2.39(m, 3H), 1.93-2.07(m, 2H), 1.66-1.92(m, 8H), 1.28-1.63(m, 4H), 0.97-1.20(m, 6H).

[0417] [Example 13]

[0418] According to the following synthesis scheme, compound A-13 represented by the following formula A-13 was synthesized.

[0419] [Chemical formula 30]

[0420]

[0421] (1) Synthesis of Compound 9

[0422] Methacrylate-2-hydroxyethyl ester (50.0 g, 0.384 mol) and butylated hydroxytoluene (1.69 g, 7.67 mmol) were dissolved in ethyl acetate (250 mL), triethylamine (45.5 g, 0.450 mol) and methanesulfonic acid chloride (46.7 g, 0.407 mol) were added under ice-cold conditions, and stirred at room temperature for 5 hours. Water (125 mL) was added to the reaction solution, and it was extracted with ethyl acetate. The organic layer obtained by extraction was washed with saturated saline, and then sodium sulfate was added. After filtering the obtained organic layer and recovering the filtrate, butylated hydroxytoluene (0.34 g, 1.54 mmol) was added, and the solvent was distilled under reduced pressure, thereby obtaining compound 9 (82.6 g).

[0423] (2) Synthesis of Compound 10

[0424] Compound 9 (76.6 g, 0.368 mol) and dibutylhydroxytoluene (0.74 g, 3.4 mmol) were dissolved in a mixed solvent of toluene (170 mL) and dimethylacetamide (190 mL), and dicyclohexyl-1,1'-dicarboxylic acid (85.0 g, 0.334 mol) and triethylamine (67.6 g, 0.668 mol) were added at room temperature, and stirred at 90°C for 5 hours. After the reaction solution was cooled to room temperature, a mixed solution of concentrated hydrochloric acid (22.1 g) and water (120 mL) was added, and then the temperature was raised to 45°C, and the water layer was removed. The obtained organic layer was washed with a mixed solution of sodium bicarbonate (12.7 g) and water (240 mL) and a mixed solution of sodium bicarbonate (2.5 g) and water (250 mL), and magnesium sulfate was added. The obtained organic layer was filtered through diatomaceous earth and the filtrate was recovered. Then, butylated hydroxytoluene (95.7 g, 0.434 mmol) was added and the solvent was distilled off from the filtrate under reduced pressure. The obtained residue was dissolved in toluene (340 mL) and hexane (630 mL) was added at 40°C. The solution was cooled to 5°C while stirring and stirred for 30 minutes. The generated crystals were filtered and washed with hexane to obtain compound 10 (26.7 g).

[0425] (3) Synthesis of Compound A-13

[0426] Phenol (1.00 g, 10.6 mmol) and compound 10 (4.87 g, 13.3 mmol) were dissolved in chloroform (10 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.75 g, 14.3 mmol) and dimethylaminopyridine (64.9 mg, 0.531 mmol) were added at room temperature, and stirred for 4 hours at room temperature. The reaction solution was purified by flash column chromatography to obtain a white solid. The obtained white solid was dissolved in chloroform (5 mL), and methanol (100 mL) was added. The solution was cooled to 0°C while stirring and stirred for 1 hour. The generated crystals were filtered and washed with methanol to obtain compound A-13 (3.71 g).

[0427] The following shows the obtained compound A-13 1 H-NMR.

[0428] 1 H-NMR (CDCl3): δ=7.37 (t, 2H), 7.23 (t, 1H), 7.04 (d, 2H), 6.11 (s, 1H), 5.59 (s, 1H), 4.27-4.39 (m, 4H), 2.4 3(tt, 1H), 2.12-2.31(m, 3H), 1.93-2.06(m, 5H), 1.76-1.90(m, 4H), 1.22-1.61(m, 4H), 0.93-1.20(m, 6H).

[0429] [Example 14]

[0430] Compound A-14 represented by the following formula A-14 was obtained as a white solid in the same manner as in Example 10 except that 2-hydroxyethyl methacrylate was used instead of 2-hydroxyethyl acrylate.

[0431] [Chemical formula 31]

[0432]

[0433] The following shows the obtained compound A-14 1 H-NMR.

[0434] 1 H-NMR (CDCl3): δ = 7.52-7.62 (m, 4H), 7.43 (t, 2H), 7.33 (t, 1H), 7.13 (d, 2H), 6.12 (s, 1H), 5.59 (s, 1H), 4.33 (br s, 4H), 2.52 (tt, 1H), 2.33 (tt, 1H), 2.09-2.28 (m, 4H), 1.95 (s, 3H), 1.46-1.69 (m, 4H).

[0435] [Example 15]

[0436] [Synthesis Example (Part 1)]

[0437] According to the following synthesis scheme, compound A-15 represented by the following formula A-15 was synthesized.

[0438] [Chemical formula 32]

[0439]

[0440] (1) Synthesis of Compound 11

[0441] Dissolved in 2-(4-hydroxyphenyl)ethanol (50.0g, 0.362mol) and dimethylacetamide (340mL), added acryloyl chloride (36.0g, 0.398mol) under ice-cold, stirred at room temperature for 4 hours. After diluting the reaction solution with ethyl acetate (400mL), 1N hydrochloric acid (250mL) was added, and extracted with ethyl acetate. The organic layer obtained by extraction was washed with saturated sodium bicarbonate aqueous solution and saturated brine in sequence, and magnesium sulfate was added. After filtering the obtained organic layer and recovering the filtrate, dibutylhydroxytoluene (0.14g, 0.64mmol) was added, and the solvent was distilled under reduced pressure to obtain compound 10 (69.6g).

[0442] (2) Synthesis of Compound 12

[0443] 1,4-cyclohexyldicarboxylic acid (55.0 g, 0.319 mol) was suspended in tetrahydrofuran (550 mL), and methanesulfonyl chloride (20.2 g, 0.176 mol) and triethylamine (19.4 g, 0.192 mol) were added under ice-cooling, and stirred at room temperature for 1 hour. Dibutylhydroxytoluene (0.18 g, 0.82 mmol), dimethylaminopyridine (1.95 g, 16.0 mmol), and compound 11 (30.7 g, 0.160 mol) were added to the reaction solution, and triethylamine (19.4 g, 0.192 mol) was added under ice-cooling, and stirred at room temperature for 2 hours. The reaction solution was filtered through celite, diluted with ethyl acetate (300 mL), and then 1N hydrochloric acid (100 mL) was added, and extracted with ethyl acetate. The obtained organic layer was washed with saturated sodium bicarbonate aqueous solution and saturated brine in sequence, and magnesium sulfate was added. After filtering the obtained organic layer and recovering the filtrate, butylated hydroxytoluene (0.14 g, 0.64 mmol) was added, and the solvent was distilled under reduced pressure. The obtained residue was dissolved in chloroform (130 mL), and hexane (260 mL) was added. The solution was stirred for 1 hour, the generated crystals were filtered, and washed with hexane, thereby obtaining compound 11 (29.8 g).

[0444] (3) Synthesis of Compound A-15

[0445] Phenol (0.94 g, 10 mmol) and compound 11 (3.46 g, 9.99 mmol) were dissolved in chloroform (15 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.30 g, 12.0 mmol) and dimethylaminopyridine (0.06 g, 0.5 mmol) were added at room temperature, and stirred for 2 hours at room temperature. The reaction solution was purified by rapid column chromatography to obtain a white solid. The obtained white solid was dissolved in ethyl acetate (15 mL), and methanol (50 mL) was added. The solution was stirred for 1 hour, the generated crystals were filtered, and washed with methanol to obtain compound A-15 (2.60 g).

[0446] The following shows the obtained compound A-15 1 H-NMR.

[0447] 1 H-NMR (CDCl3): δ=7.38 (t, 2H), 7.21-7.24 (m, 3H), 7.08 (d, 2H), 7.02 (d, 2H), 6.39 (d, 1H), 6.12 (dd, 1 H), 5.81 (d, 1H), 4.36 (t, 2H), 2.98 (t, 2H), 2.68-2.50 (m, 2H), 2.18-2.37 (m, 4H), 1.58-1.78 (m, 4H).

[0448] [Synthesis Example (Part 2)]

[0449] According to the following synthesis scheme, compound A-15 represented by the following formula A-15 was synthesized.

[0450] [Chemical formula 33]

[0451]

[0452] (1) Synthesis of Compound 11

[0453] 2-(4-Hydroxyphenyl)ethanol (19.3 g, 0.14 mol) was dissolved in toluene (80 mL) and dimethylacetamide (24 mL) and the temperature was raised to 60°C. 3-Chloropropionyl chloride (17.8 g, 0.14 mol) was added dropwise and reacted at 60-70°C for 2 hours. 2,6-di-tert-butyl-p-cresol (0.15 g) was added thereto, and triethylamine (42.5 g, 0.42 mol) was added dropwise and reacted at 60-70°C for 2 hours. After the reaction was completed, the internal temperature was lowered to below 25°C, and water (51 mL) and concentrated hydrochloric acid (16 g) were added to perform a liquid separation operation. Water (68 mL) was added to the organic layer obtained by extraction, and a liquid separation operation was performed again to obtain an organic layer. 2,6-di-tert-butyl-p-cresol (0.3 g) was added thereto, and toluene was distilled off under reduced pressure. Furthermore, toluene (42 g) was added and the mixture was distilled under reduced pressure again to obtain Compound 11 (23 g).

[0454] (2) Synthesis of Compound 12A

[0455] 1,4-cyclohexyldicarboxylic acid dichloride (79.9 g, 0.38 mol) was dissolved in ethyl acetate (89 mL) and tetrahydrofuran (194 mL), and the external temperature was set to 5°C and cooled, and a 67% THF solution of phenol (27.7 g, 0.294 mol) was added. Triethylamine (35.7 g, 0.35 mol) was added dropwise, and the reaction was carried out at an internal temperature of 5 to 15°C for 0.5 hours. After the reaction was completed, water (29 mL) was added dropwise, and a mixed solution of water (76 mL) and a 40% sodium hydroxide aqueous solution (62 g) was added dropwise. After that, the reaction was carried out at an internal temperature of 15 to 25°C for 0.5 hours, and N-methylimidazole (18 g) was added dropwise, and the reaction was further carried out at an internal temperature of 35 to 40°C for 1 hour. Thereafter, acetic acid (2.7 g) was added dropwise to carry out a liquid separation operation. Then, water (58mL) and concentrated hydrochloric acid (17.7g) were added to the organic layer, and a liquid separation operation was performed. Finally, water (133mL) and salt (2.9g) were added, and a liquid separation operation was performed to extract the organic layer. Toluene (70mL) was added to the organic layer and vacuum distilled, and then toluene (70mL) was added and vacuum distilled again. Toluene (388mL) was added thereto, and vacuum filtration was performed, and a mixed solution of cyclohexane (29mL) and isopropanol (7.5mL) was used for washing, and the mixture was dried at room temperature overnight to obtain compound 12A (33g).

[0456] (3) Synthesis of Compound A-15

[0457] Compound 12A (28.4 g, 0.114 mol) was dissolved in toluene (59 mL) and dimethylformamide (22 mL), and thionyl chloride (15.1 g, 0.127 mol) was added dropwise so that the internal temperature was 20 to 40°C, and the reaction was carried out at an internal temperature of 30 to 40°C for 1 hour. After leaving the mixture to stand and removing the bottom layer, ethyl acetate (91 mL) was added, and the internal temperature was cooled to 5°C. N-methylimidazole (1.9 g) was added dropwise, and 2,6-di-tert-butyl-p-cresol (0.25 g) was added. A solution of compound 11 (39.5 g, 0.104 mol) in ethyl acetate (30 mL) was added dropwise to the reaction solution, and then triethylamine (21.1 g, 0.21 mol) was added dropwise, and the reaction was carried out at an internal temperature of 30 to 40°C for 2 hours. After that, methanol (5.7 mL) was added dropwise and stirred for 15 to 30 minutes, and water (34 mL) and ethyl acetate (28 mL) were continuously added, and dust removal and filtration were performed. Water (165 mL) and concentrated hydrochloric acid (1.4 g) were added thereto, and a liquid separation operation was performed. Next, water (180 mL) and salt (20 g) were added to the extracted organic layer for a liquid separation operation, and the organic layer was extracted. A mixed solution of methanol (400 mL) and water (140 mL) was added dropwise to the obtained organic layer, and after the internal temperature was cooled to 5°C and stirred for 0.5 hours, reduced pressure filtration was performed to obtain compound A-15 (35 g).

[0458] [Example 16]

[0459] Compound A-16 represented by the following formula A-16 was obtained as a white solid in the same manner as in Example 15 except that methacryloyl chloride was used instead of acryloyl chloride.

[0460] [Chemical formula 34]

[0461]

[0462] The following shows the obtained compound A-16 1 H-NMR.

[0463] 1 H-NMR (CDCl3): δ=7.4 (t, 2H), 7.2-7.3 (m, 3H), 7.1 (d, 2H), 7.0 (d, 2H), 6.1 (s, 1H), 5.55 ( s, 1H), 4.3 (t, 2H), 3.0 (t, 2H), 2.5-2.65 (m, 2H), 2.3 (m, 4H), 1.9 (s, 3H), 1.6-1.7 (m, 4H).

[0464] [Example 17]

[0465] Compound A-17 represented by the following formula A-17 was obtained as a white solid by the same procedure as in Example 15 except that o-methoxyphenol was used instead of phenol.

[0466] [Chemical formula 35]

[0467]

[0468] The following shows the obtained compound A-17 1 H-NMR.

[0469] 1 H-NMR (CDCl3): δ=7.2-7.3(m, 3H), 6.9-7.1(m, 5H), 6.4(d, 1H), 6.1(dd, 1H), 5.80(d, 1H) , 4.35 (t, 2H), 3.8 (s, 3H), 3.0 (t, 3H), 2.5-2.7 (m, 2H), 2.2-2.4 (m, 4H), 1.6-1.8 (m, 4H).

[0470] [Comparative Example 1]

[0471] According to the description of Japanese Patent Application Laid-Open No. 2010-100609, a compound B-1 represented by the following formula B-1 was synthesized.

[0472] [Chemical formula 36]

[0473]

[0474] [Comparative Example 2]

[0475] According to the description of Japanese Patent Application Laid-Open No. 2011-246365, a compound B-2 represented by the following formula B-2 was synthesized.

[0476] [Chemical formula 37]

[0477]

[0478] [Comparative Example 3]

[0479] According to the description of Japanese Patent Application Laid-Open No. 2018-77465, compound B-3 represented by the following formula B-3 was synthesized.

[0480] [Chemical formula 38]

[0481]

[0482] [Comparative Example 4]

[0483] According to the description of International Publication No. 2012 / 002140, compound B-4 represented by the following formula B-4 was synthesized.

[0484] [Chemical formula 39]

[0485]

[0486] [Comparative Example 5]

[0487] According to the description of JP-A-2015-166887, compound B-5 represented by the following formula B-5 was synthesized.

[0488] [Chemical formula 40]

[0489]

[0490] [Comparative Example 6]

[0491] According to the description of JP-A-2013-152439, compound B-6 represented by the following formula B-6 was synthesized.

[0492] [Chemical formula 41]

[0493]

[0494] [Comparative Example 7]

[0495] According to the description of JP-A-2016-126941, compound B-7 represented by the following formula B-7 was synthesized.

[0496] [Chemical formula 42]

[0497]

[0498] [Production of optical films]

[0499] <Production of substrate with oriented film>

[0500] The following coating liquid for forming an alignment film was applied onto the cleaned glass substrate using a #5 bar coater, and the glass substrate was dried with 100° C. hot air for 120 seconds and then rubbed to prepare a substrate with an alignment film.

[0501]

[0502] <Formation of positive A plate>

[0503] The following composition was applied to the substrate with the oriented film by spin coating. The coating film formed on the substrate with the oriented film was heated at 150°C with hot air, then cooled to 105°C, and irradiated with 10 mJ / cm2 of light at a wavelength of 365 nm using a high-pressure mercury lamp in a nitrogen atmosphere. 2 The coating film was then irradiated with 500 mJ / cm2 of ultraviolet light while being heated to 120°C. 2 The ultraviolet rays are irradiated to fix the orientation of the liquid crystal compound, thereby producing an optical film including a positive A plate.

[0504]

[0505] Polymerizable liquid crystal compound L-1 [Chemical Formula 43]

[0506]

[0507] Polymerizable liquid crystal compound L-2 [Chemical Formula 44]

[0508]

[0509] Polymerizable liquid crystal compound L-3 [Chemical Formula 45]

[0510]

[0511] Polymerization initiator PI-1

[0512] [Chemical formula 46]

[0513]

[0514] Leveling agent T-1

[0515] [Chemical formula 47]

[0516]

[0517] [evaluate]

[0518] <Moisture and heat resistance>

[0519] A pressure-sensitive adhesive (SK-2057, manufactured by Soken Chemical & Engineering Co., Ltd.) was used to bond a glass plate to the coated surface of the prepared positive A plate, and the substrate with the oriented film was peeled off from the glass plate, thereby transferring only the positive A plate to the glass plate, and after 136 hours at 100°C and 95% humidity, the Re change rate was evaluated by comparison with the same sample not exposed to high temperature and high humidity. In the following Table 4, "A" indicates that the Re change rate is less than 5%, "B" indicates that the Re change rate is 5% or more and less than 10%, and "C" indicates that it is 10% or more.

[0520] <Measurement of tilt angle>

[0521] The tilt angle refers to the value of the positive A plate on the substrate with an oriented film produced by directly measuring the positive A plate using AxoScan OPMF-1 (manufactured by Opto Science, Inc.) using light of a wavelength of 550 nm. In the following Table 4, "A" means that the tilt angle is less than 7.0°, "B" means that the tilt angle is 7.0° or more and less than 9.3°, "C" means that the tilt angle is 9.3° or more and less than 10.0°, and "D" means that the tilt angle is 10.0° or more.

[0522] [Table 4]

[0523]

[0524] From the results shown in Table 4, it can be seen that when compounds B-1 to B-7 not corresponding to the above formula (I) were used, the tilt angle of the liquid crystal molecules became 10° or more (Comparative Examples 1 to 7).

[0525] In contrast, it was found that when compounds A-1 to A-14 not corresponding to the above formula (I) were used, the tilt angle of the liquid crystal molecules became smaller (Examples 1 to 17).

[0526] In particular, from the comparison results of Examples 1 and 3 to 6 and the comparison results of Examples 7 and 8, it can be seen that in the above formula (I), A 2 In the case of an aromatic ring having a substituent R, when the substituent R is a substituent represented by -Z-Sp-P, the moist heat resistance is improved.

[0527] Furthermore, it is known that when Sp in the above formula (I) is a linear or branched alkylene group having 1 to 3 carbon atoms or when m in the above formula (I) is 0, the tilt angle of the liquid crystal molecule becomes smaller.

[0528] Furthermore, from the comparison between Example 10 and Example 14, it can be seen that if the compound (I) and the polymerizable liquid crystal compound have different polymerizable groups, the tilt angle of the liquid crystal molecules becomes smaller.

[0529] [Examples 18 and 19]

[0530] 〔Production of optical films〕

[0531] <Production of substrate with oriented film>

[0532] The following coating liquid for forming an alignment film was applied onto the cleaned glass substrate using a #5 bar coater, and the glass substrate was dried with 100° C. hot air for 120 seconds and then rubbed to prepare a substrate with an alignment film.

[0533]

[0534] <Formation of positive A plate>

[0535] The following composition was applied to the substrate with the oriented film by spin coating. The coating film formed on the substrate with the oriented film was heated at 150°C with hot air, then cooled to 105°C, and irradiated with 10 mJ / cm2 of light at a wavelength of 365 nm using a high-pressure mercury lamp in a nitrogen atmosphere. 2 The coating film was then irradiated with 500 mJ / cm2 of ultraviolet light while being heated to 120°C. 2 The ultraviolet rays are irradiated to fix the orientation of the liquid crystal compound, thereby producing an optical film including a positive A plate.

[0536]

[0537]

[0538] Polymerizable liquid crystal compound L-1

[0539] [Chemical formula 48]

[0540]

[0541] Polymerizable liquid crystal compound L-2

[0542] [Chemical formula 49]

[0543]

[0544] Polymerizable liquid crystal compound L-13

[0545] [Chemical formula 50]

[0546]

[0547] The tilt angle of the positive A plate on the substrate with an oriented film was measured by the above method for the optical films produced in Examples 18 and 19. The results are shown in Table 5. In Table 5, "A" means that the tilt angle is less than 7.0°.

[0548] [Table 5]

[0549]

[0550] [Examples 20 and 21]

[0551] An optical film including a positive A plate was produced by the same method as in Example 18 except that the method for forming the positive A plate was changed to the method and composition shown below.

[0552] <Formation of positive A plate>

[0553] The following composition was applied to the substrate with the oriented film by spin coating. The coating film formed on the substrate with the oriented film was heated at 150°C with hot air, then cooled to 105°C, and irradiated with 10 mJ / cm2 of light at a wavelength of 365 nm using a high-pressure mercury lamp in a nitrogen atmosphere. 2 The coating film was then irradiated with 500 mJ / cm2 of ultraviolet light while being heated to 120°C. 2 The ultraviolet rays are irradiated to fix the orientation of the liquid crystal compound, thereby producing an optical film including a positive A plate.

[0554]

[0555] Polymerizable liquid crystal compound L-14

[0556] [Chemical formula 51]

[0557]

[0558] Polymerizable liquid crystal compound L-15

[0559] [Chemical formula 52]

[0560]

[0561] The tilt angle of the positive A plate on the substrate with an oriented film was measured by the above method for the optical films produced in Examples 20 and 21. The results are shown in Table 6. In Table 6, "A" means that the tilt angle is less than 7.0°.

[0562] [Table 6]

[0563]

[0564] [Examples 22 to 26 and Comparative Examples 8 to 9]

[0565] An optical film including a positive A plate was produced by the same method as in Example 18 except that the method for forming the positive A plate was changed to the method and composition shown below.

[0566] <Formation of positive A plate>

[0567] The following composition was applied to the substrate with the oriented film by spin coating. The coating film formed on the substrate with the oriented film was heated at 150°C with hot air, then cooled to 60°C, and irradiated with 10 mJ / cm2 of light at a wavelength of 365 nm using a high-pressure mercury lamp in a nitrogen atmosphere. 2 The coating film was then irradiated with 500 mJ / cm2 of ultraviolet light while being heated to 120°C. 2 The ultraviolet rays are irradiated to fix the orientation of the liquid crystal compound, thereby producing an optical film including a positive A plate.

[0568]

[0569] In addition, the group adjacent to the acryloyloxy group in the structural formulas of the polymerizable liquid crystal compounds L-4 and L-5 shown below represents a propylene group (a group in which a methyl group is substituted by an ethylene group), and the polymerizable liquid crystal compounds L-4 and L-5 represent a mixture of positional isomers in which the positions of the methyl groups are different.

[0570] Polymerizable liquid crystal compound L-4

[0571] [Chemical formula 53]

[0572]

[0573] Polymerizable liquid crystal compound L-5

[0574] [Chemical formula 54]

[0575]

[0576] The tilt angle of the positive A plate on the substrate with an oriented film was measured by the above method for the optical films produced in Examples 22 to 26 and Comparative Examples 8 to 9. The results are shown in Table 7 below. In Table 7 below, "A" indicates that the tilt angle is less than 7.0°, "B" indicates that the tilt angle is 7.0° or more and less than 9.3°, and "D" indicates that the tilt angle is 10.0° or more.

[0577] [Table 7]

[0578]

[0579] In the above Table 7, the structures of compound A-1 and the like are as shown in Example 1 and the like, and the structure of compound O-3 is as shown below.

[0580] [Chemical formula 55]

[0581]

[0582] [Examples 27 to 61 and Comparative Examples 10 to 16]

[0583] An optical film including a positive A plate was produced by the same method as in Example 18 except that the method for forming the positive A plate was changed to the method and composition shown below.

[0584] <Formation of positive A plate>

[0585] Using the following composition, an optical film including a positive A plate was prepared by the same method as in Example 22, except that the temperature when irradiating the coating with ultraviolet rays was set to a temperature 35°C lower than the phase transition temperature between the smectic phase and the nematic phase of the polymerizable liquid crystal compound in Table 8 below.

[0586]

[0587] For the optical films produced in Examples 27 to 61 and Comparative Examples 10 to 16, the tilt angle of the positive A plate on the substrate with an oriented film was measured by the above method. The results are shown in Table 8 below. In Table 8 below, "A" indicates that the tilt angle is less than 7.0°, "B" indicates that the tilt angle is 7.0° or more and less than 9.3°, "C" indicates that the tilt angle is 9.3° or more and less than 10.0°, and "D" indicates that the tilt angle is 10.0° or more.

[0588] [Table 8]

[0589]

[0590] In the above Table 8, the structures of compound A-1 and the like are as shown in Example 1 and the like, and the structures of the polymerizable liquid crystal compound and compounds O-3 and O-5 are as shown below.

[0591] Polymerizable liquid crystal compound L-6

[0592] [Chemical formula 56]

[0593]

[0594] Polymerizable liquid crystal compound L-7 [Chemical Formula 57]

[0595]

[0596] Polymerizable liquid crystal compound L-8 [Chemical Formula 58]

[0597]

[0598] Polymerizable liquid crystal compound L-9 [Chemical Formula 59]

[0599]

[0600] Polymerizable liquid crystal compound L-10 [Chemical formula 60]

[0601]

[0602] Polymerizable liquid crystal compound L-11

[0603] [Chemical formula 61]

[0604]

[0605] Polymerizable liquid crystal compound L-12

[0606] [Chemical formula 62]

[0607]

[0608] Compound O-3

[0609] [Chemical formula 63]

[0610]

[0611] Compound O-5

[0612] [Chemical formula 64]

[0613]

[0614] Explanation of symbols

[0615] 10- optical film, 12- optically anisotropic layer, 14- oriented film, 16- support, 18- hard coating layer.

Claims

1. A compound represented by the following formula (I): P-Sp-Z-G 1 -(X 1 -Cy 1 )n-(X 2 -A 1 )m-X 3 -A 2 (I) Here, in the formula (I), Sp represents a single bond, a linear or branched alkylene group having 1 to 12 carbon atoms, or a divalent linking group in which one or more -CH2- constituting a linear or branched alkylene group having 1 to 12 carbon atoms is substituted with -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent, Z represents a single bond, -O-, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, Q represents a substituent, X 1 , X 2 and X 3 each independently represents a single bond, -COO-, -OCO-, -CO-NH- or -NH-CO-, G 1 represents an aromatic ring which may have a substituent or a 1,4-cyclohexylene group which may have a substituent, Cy 1 represents a 1,4-cyclohexylene group which may have a substituent, A 1 represents an aromatic ring which may have a substituent, A 2 represents an unsubstituted aromatic ring or an unsubstituted cyclohexane ring, n represents 0 or 1, m represents an integer from 0 to 2, n+m represents an integer from 1 to 3, when m is 2, there are 2 X in the formula 2 and A 1 can be the same or different from each other, The substituent is an alkyl group, an alkoxy group or a halogen atom, The aromatic ring is a benzene ring, a naphthalene ring or a pyridine ring, P in the formula (I) is a polymerizable group represented by any one of the following formulae (P-1) to (P-9), in, When G 1 When it is an aromatic ring which may have a substituent, n is 0, and m is 1, X 3 represents -COO-, -OCO-, -CO-NH- or -NH-CO-, And, when G 1 is an aromatic ring which may have a substituent, n is 1, m is 0, A 2 When it is an unsubstituted aromatic ring, Z represents a single bond, -S-, -NH-, -N(Q)-, -CO-, -COO-, -OCO-, -CO-NH- or -NH-CO-, and Q represents a substituent. When Z is a single bond, the divalent linking group constituting Sp is 1 The adjacent atom is not an oxygen atom.

2. The compound according to claim 1, wherein A in the formula (I) 1 represents an unsubstituted aromatic ring.

3. The compound according to claim 1, wherein A in the formula (I) 1 represents an aromatic ring having a substituent.

4. The compound according to any one of claims 1 to 3, wherein In the above formula (I), n and m are 1 in total.

5. The compound according to any one of claims 1 to 3, wherein Sp in the above formula (I) is a linear or branched alkylene group having 1 to 3 carbon atoms.

6. The compound according to any one of claims 1 to 3, wherein A in the formula (I) 2 It is an unsubstituted aromatic ring.

7. The compound according to any one of claims 1 to 3, wherein A in the formula (I) 2 It is an unsubstituted benzene ring.

8. The compound according to any one of claims 1 to 3, wherein In the formula (I), m is 0.

9. The compound according to any one of claims 1 to 3, wherein In the formula (I), n is 1.

10. The compound according to any one of claims 1 to 3, wherein In the formula (I), n is 0.

11. The compound according to any one of claims 1 to 3, wherein In the formula (I), G 1 It is a 1,4-cyclohexylene group which may have a substituent.

12. The compound according to any one of claims 1 to 3, wherein In the formula (I), G 1 It is an aromatic ring which may have a substituent. 13 . A polymerizable composition comprising the compound according to claim 1 .

14. The polymerizable composition according to claim 13, wherein The polymerizable composition contains a polymerizable liquid crystal compound different from the compound.

15. The polymerizable composition according to claim 14, wherein The compound and the polymerizable liquid crystal compound have different polymerizable groups.

16. The polymerizable composition according to claim 13, wherein The polymerizable composition contains a polymerization initiator.

17. A cured product obtained by curing the polymerizable composition according to any one of claims 13 to 16. 18 . An optical film comprising the cured product according to claim 17 .

19. A polarizing plate comprising the optical film according to claim 18 and a polarizer. 20 . An image display device comprising the optical film according to claim 18 or the polarizing plate according to claim 19 .

Citation Information

Patent Citations

  • Liquid crystal display device

    JP1990176625A

  • Phase difference plate and liquid crystal device provided with the same

    JP1997292522A

  • Liquid crystal display device

    JP1998054982A

  • Horizontal electric field type liquid crystal display device

    JP1999133408A

  • Liquid crystal display device and its manufacture

    JP1999202323A